UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

      

FORM 10-Q

   

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 001-34581

      

      

LOGO

KRATON PERFORMANCE POLYMERS, INC.

(Exact Name of Registrant as Specified in its Charter)

      

   

 

Delaware

20-0411521

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

   

   

15710 John F. Kennedy Blvd.

Suite 300

Houston, TX 77032

281-504-4700

(Address of principal executive offices, including zip code)

(Registrant’s telephone number, including area code)

      

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act. (Check one):

   

 

Large accelerated filer:

x

Accelerated filer:

¨

Non-accelerated filer:

¨

Smaller reporting company:

¨

   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

Number of shares of Kraton Performance Polymers, Inc. Common Stock, $0.01 par value, outstanding as of October 28, 2013: 32,528,011.

      

   

   

   

   


   

Index to Quarterly Report

on Form 10-Q for

Quarter Ended September 30, 2013

   

   

 

PART I. FINANCIAL INFORMATION

Page

Item 1

      

Condensed Consolidated Financial Statements (Unaudited)  

 

 6

   

      

Condensed Consolidated Balance Sheets as of September 30, 2013 and December 31, 2012  

 

 6

   

      

Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012  

 

 7

   

      

Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2013 and 2012  

 

 8

   

      

Condensed Consolidated Statements of Changes in Equity for the nine months ended September 30, 2013 and 2012  

 

 9

   

      

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2013 and 2012  

 

 10

   

      

Notes to the Condensed Consolidated Financial Statements  

 

 11

Item 2

      

Management’s Discussion and Analysis of Financial Condition and Results of Operations  

 

 37

Item 3

      

Quantitative and Qualitative Disclosures About Market Risk  

 

 52

Item 4

      

Controls and Procedures  

 

 52

PART II. OTHER INFORMATION

   

Item 1

      

Legal Proceedings  

 

 53

Item 1A

      

Risk Factors  

 

 53

Item 6

      

Exhibits  

 

 54

   

      

Signatures  

 

 55

   

   

   

       

 

 2 


   

   

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Some of the statements in this Quarterly Report on Form 10-Q under the headings “Condensed Consolidated Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We may also make written or oral forward-looking statements in our periodic reports on Forms 10-K, 10-Q and 8-K, in press releases and other written materials and in oral statements made by our officers, directors or employees to third parties. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as “believes,” “estimates,” “expects,” “projects,” “may,” “intends,” “plans” or “anticipates,” or by discussions of strategy, plans or intentions; anticipated benefits of or performance of our products; beliefs regarding opportunities for new, high-margin applications and other innovations; adequacy of cash flows to fund our working capital requirements; our investment in the joint venture with FPCC; debt payments, interest payments, capital expenditures, benefit plan contributions, and income tax obligations; our anticipated 2013 capital expenditures, compliance with the MACT rule, health, safety and environmental and infrastructure and maintenance projects, projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform; our ability to meet conditions required to ensure full access to our senior secured credit facilities; expectations regarding our counterparties’ ability to perform, including with respect to trade receivables; estimates regarding the tax expense of repatriating certain cash and short-term investments related to foreign operations; expectations regarding high-margin applications; our ability to realize certain deferred tax assets and our beliefs with respect to tax positions; expectations regarding our full year effective tax rate; our plans and expectations regarding our Asia expansion project; estimates related to the useful lives of certain assets for tax purposes; expectations regarding our pension contributions for fiscal year 2013; estimates or expectations related to monomer costs, ending inventory levels and related estimated charges; the outcome and financial impact of legal proceedings; expectations regarding the spread between FIFO and ECRC in future periods; and projections regarding environmental costs and capital expenditures and related operational savings. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward-looking statements. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Further description of these risks and uncertainties and other important factors are set forth in this report, in our latest Annual Report on Form 10-K, including but not limited to “Part I, Item 1A. Risk Factors” and “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” therein, and in our other filings with the Securities and Exchange Commission, and include, but are not limited to, risks related to:

 

·

conditions in the global economy and capital markets;

 

·

our reliance on LyondellBasell Industries for the provision of significant operating and other services;

 

·

the failure of our raw materials suppliers to perform their obligations under long-term supply agreements, or our inability to replace or renew these agreements when they expire;

 

·

limitations in the availability of raw materials we need to produce our products in the amounts or at the prices necessary for us to effectively and profitably operate our business;

 

·

significant fluctuations in raw material costs may result in volatility in our quarterly operating results and impact the market price of our common stock;

 

·

competition in our end use markets by other producers of styrenic block copolymers and by producers of products that can be substituted for our products;

 

·

our ability to produce and commercialize technological innovations;

 

·

our ability to protect our intellectual property, on which our business is substantially dependent;

 

·

the possibility that our products infringe upon the intellectual property rights of others;

 

·

seasonality in our business, particularly in our Paving and Roofing end use market;

 

 3 


   

   

 

·

our substantial indebtedness, which could adversely affect our financial condition and prevent us from fulfilling our obligations under the loan agreement and the senior notes;

 

·

financial and operating constraints related to our indebtedness;

 

·

the inherently hazardous nature of chemical manufacturing;

 

·

product liability claims and other lawsuits arising from environmental damage, personal injuries, other damages associated with chemical manufacturing or our products;

 

·

political, economic and local business risks in the various countries in which we operate;

 

·

health, safety and environmental laws, including laws that govern our employees’ exposure to chemicals deemed harmful to humans;

 

·

regulation of our company or our customers, which could affect the demand for our products or result in increased compliance and other costs;

 

·

customs, international trade, export control, antitrust, zoning and occupancy and labor and employment laws that could require us to modify our current business practices and incur increased costs;

 

·

fluctuations in currency exchange rates;

 

·

we may have additional tax liabilities;

 

·

our formation of a joint venture to expand HSBC capacity in Asia is subject to risks and uncertainties;

 

·

our relationship with our employees;

 

·

loss of key personnel or our inability to attract and retain new qualified personnel;

 

·

the fact that we generally do not enter into long-term contracts with our customers;

 

·

a decrease in the fair value of our pension assets could require us to materially increase future funding requirements of the pension plan;

 

·

domestic or international natural disasters or terrorist attacks may disrupt our operations;

 

·

Delaware law and some provisions of our organizational documents that make a takeover of our company more difficult;

 

·

our expectation that we will not pay dividends for the foreseeable future; and

 

·

we are a holding company with nominal net worth and will depend on dividends and distributions from our subsidiaries to pay any dividends.

There may be other factors of which we are currently unaware or that we deem immaterial that may cause our actual results to differ materially from the expectations we express in our forward-looking statements. Although we believe the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and, therefore, also the forward-looking statements based on these assumptions could themselves prove to be inaccurate.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them publicly in light of new information or future events.

 

 4 


   

Presentation of Financial Statements

The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries. This Form 10-Q includes financial statements and related notes that present the condensed consolidated financial position, results of operations, comprehensive income, and cash flows of Kraton and its subsidiaries. Kraton is a holding company whose only material asset is its investment in its wholly owned subsidiary, Kraton Polymers LLC. Kraton Polymers LLC and its subsidiaries own all of our consolidated operating assets.

   

   

 

 5 


   

PART I. FINANCIAL INFORMATION

 

Item 1.

Condensed Consolidated Financial Statements.

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except par value)

      

 

   

September 30,
2013

   

   

December 31,
2012

   

ASSETS

   

   

   

   

   

   

   

Current assets:

   

   

   

   

   

   

   

Cash and cash equivalents

$

144,630

      

   

$

223,166

      

Receivables, net of allowances of $414 and $401

   

142,886

      

   

   

124,635

      

Inventories of products

   

313,775

      

   

   

340,323

      

Inventories of materials and supplies

   

10,694

      

   

   

10,331

      

Deferred income taxes

   

9,032

      

   

   

7,869

      

Other current assets

   

19,601

      

   

   

28,363

      

Total current assets

   

640,618

      

   

   

734,687

      

Property, plant and equipment, less accumulated depreciation of $346,587 and  $311,779

   

402,609

      

   

   

381,205

      

Intangible assets, less accumulated amortization of $76,152 and $68,531

   

58,447

      

   

   

63,393

      

Investment in unconsolidated joint venture

   

13,754

      

   

   

13,582

      

Debt issuance costs

   

9,756

      

   

   

10,846

      

Deferred income taxes

   

617

      

   

   

79

      

Other long-term assets

   

26,047

      

   

   

25,397

      

Total assets

$

1,151,848

      

   

$

1,229,189

      

LIABILITIES AND EQUITY

   

   

   

   

   

   

   

Current liabilities:

   

   

   

   

   

   

   

Current portion of long-term debt

$

0

      

   

$

15,074

      

Accounts payable-trade

   

93,193

      

   

   

99,167

      

Other payables and accruals

   

39,687

      

   

   

50,978

      

Deferred income taxes

   

412

      

   

   

513

      

Due to related party

   

22,813

      

   

   

16,080

      

Total current liabilities

   

156,105

      

   

   

181,812

      

Long-term debt, net of current portion

   

351,028

      

   

   

432,943

      

Deferred income taxes

   

21,355

      

   

   

22,273

      

Other long-term liabilities

   

103,051

      

   

   

99,946

      

Total liabilities

   

631,539

      

   

   

736,974

      

Commitments and contingencies (note 10)

   

   

   

   

   

   

   

Equity:

   

   

   

   

   

   

   

Kraton stockholders’ equity:

   

   

   

   

   

   

   

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

   

0

      

   

   

0

      

Common stock, $0.01 par value; 500,000 shares authorized; 32,528 shares issued and outstanding at September 30, 2013; 32,277 shares issued and outstanding at December 31, 2012

   

325

      

   

   

323

      

Additional paid in capital

   

361,627

      

   

   

354,957

      

Retained earnings

   

165,928

      

   

   

171,445

      

Accumulated other comprehensive loss

   

(37,898

   

   

(34,510

Total Kraton stockholders’ equity

   

489,982

      

   

   

492,215

      

Noncontrolling interest

   

30,327

      

   

   

0

      

Total equity

   

520,309

      

   

   

492,215

      

Total liabilities and equity

$

1,151,848

      

   

$

1,229,189

      

   

See Notes to Condensed Consolidated Financial Statements

   

   

 

 6 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

      

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

Sales revenue

$

327,109

   

   

$

342,635

   

   

$

1,001,759

   

   

$

1,126,704

   

Cost of goods sold

   

279,659

   

   

   

299,882

   

   

   

834,537

   

   

   

934,952

   

Gross profit

   

47,450

   

   

   

42,753

   

   

   

167,222

   

   

   

191,752

   

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Research and development

   

7,413

   

   

   

7,401

   

   

   

23,772

   

   

   

22,957

   

Selling, general and administrative

   

22,430

   

   

   

23,447

   

   

   

73,548

   

   

   

76,223

   

Depreciation and amortization

   

15,814

   

   

   

16,109

   

   

   

46,653

   

   

   

47,843

   

Impairment of long-lived assets

   

0

   

   

   

5,434

   

   

   

0

   

   

   

5,434

   

Total operating expenses

   

45,657

   

   

   

52,391

   

   

   

143,973

   

   

   

152,457

   

Earnings of unconsolidated joint venture

   

117

   

   

   

133

   

   

   

372

   

   

   

433

   

Interest expense, net

   

5,741

   

   

   

7,634

   

   

   

24,948

   

   

   

22,106

   

Income (loss) before income taxes

   

(3,831

)

   

   

(17,139

)

   

   

(1,327

)

   

   

17,622

   

Income tax expense (benefit)

   

2,021

   

   

   

(1,640

)

   

   

4,372

   

   

   

4,361

   

Consolidated net income (loss)

   

(5,852

)

   

   

(15,499

)

   

   

(5,699

)

   

   

13,261

   

Net loss attributable to noncontrolling interest

   

(254

)

   

   

0

   

   

   

(182

)

   

   

0

   

Net income (loss) attributable to Kraton

$

(5,598

)

   

$

(15,499

)

   

$

(5,517

)

   

$

13,261

   

Earnings (loss) per common share:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

$

(0.17

)

   

$

(0.48

)

   

$

(0.17

)

   

$

0.41

   

Diluted

$

(0.17

)

   

$

(0.48

)

   

$

(0.17

)

   

$

0.41

   

Weighted average common shares outstanding:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Basic

   

32,073

   

   

   

31,943

   

   

   

32,069

   

   

   

31,927

   

Diluted

   

32,073

   

   

   

31,943

   

   

   

32,069

   

   

   

32,202

   

   

   

   

   

   

   

   

   

   

   

   

See Notes to Condensed Consolidated Financial Statements.

   

   

 

 7 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands)

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

Net income (loss) attributable to Kraton

$

(5,598

)

   

$

(15,499

)

   

$

(5,517

)

   

$

13,261

   

Other comprehensive income (loss):

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Foreign currency translation adjustments, net of tax of $0

   

9,511

   

   

   

7,020

   

   

   

(3,735

)

   

   

(6,025

)

Unrealized gain (loss) of interest rate swaps, net of tax of $0

   

0

   

   

   

(9

)

   

   

837

   

   

   

(143

)

Unrealized gain (loss) of net investment hedge, net of tax of $0

   

(265

)

   

   

(1,155

)

   

   

(490

)

   

   

648

   

Other comprehensive income (loss), net of tax

   

9,246

   

   

   

5,856

   

   

   

(3,388

)

   

   

(5,520

)

Comprehensive income (loss) attributable to Kraton

   

3,648

   

   

   

(9,643

)

   

   

(8,905

)

   

   

7,741

   

Comprehensive income attributable to noncontrolling interest

   

178

   

   

   

0

   

   

   

111

   

   

   

0

   

Consolidated comprehensive income (loss)

$

3,826

   

   

$

(9,643

)

   

$

(8,794

)

   

$

7,741

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

See Notes to Condensed Consolidated Financial Statements

   

   

 

 8 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)

(In thousands)

   

 

   

Common
Stock

   

      

Additional
Paid in
Capital

   

      

Retained
Earnings

   

      

Accumulated
Other
Comprehensive
Income (Loss)

   

   

Total Kraton
Stockholders’
Equity

   

   

Noncontrolling
Interest

   

   

Total
Equity

   

Balance at December 31, 2011

$

321

      

      

$

347,455

      

      

$

187,636

      

      

$

(17,618

   

$

517,794

      

   

$

0

      

   

$

517,794

      

Net income

   

0

      

      

   

0

      

      

   

13,261

      

      

   

0

      

   

   

13,261

      

   

   

0

      

   

   

13,261

      

Other comprehensive loss

   

0

      

      

   

0

      

      

   

0

      

      

   

(5,520

   

   

(5,520

   

   

0

      

   

   

(5,520

Exercise of stock options

   

2

      

      

   

818

      

      

   

0

      

      

   

0

      

   

   

820

      

   

   

0

      

   

   

820

      

Non-cash compensation related to equity awards

   

0

      

      

   

5,245

      

      

   

0

      

      

   

0

      

   

   

5,245

      

   

   

0

      

   

   

5,245

      

Balance at September 30, 2012

$

323

      

      

$

353,518

      

      

$

200,897

      

      

$

(23,138

   

$

531,600

      

   

$

0

      

   

$

531,600

      

Balance at December 31, 2012

$

323

      

      

$

354,957

      

      

$

171,445

      

      

$

(34,510

   

$

492,215

      

   

$

0

      

   

$

492,215

      

Net loss

   

0

      

      

   

0

      

      

   

(5,517

      

   

0

      

   

   

(5,517

   

   

(182

   

   

(5,699

Other comprehensive income (loss)

   

0

      

      

   

0

      

      

   

0

      

      

   

(3,388

   

   

(3,388

   

   

293

   

   

   

(3,095

Consolidation of variable interest  entity

   

0

      

      

   

0

      

      

   

0

      

      

   

0

      

   

   

0

      

   

   

30,216

      

   

   

30,216

      

Exercise of stock options

   

2

      

      

   

308

      

      

   

0

      

      

   

0

      

   

   

310

      

   

   

0

      

   

   

310

      

Non-cash compensation related to equity awards

   

0

      

      

   

6,362

      

      

   

0

      

      

   

0

      

   

   

6,362

      

   

   

0

      

   

   

6,362

      

Balance at September 30, 2013

$

325

      

      

$

361,627

      

      

$

165,928

      

      

$

(37,898

   

$

489,982

      

   

$

30,327

      

   

$

520,309

      

   

   

   

   

   

   

   

   

   

   

   

   

   

   

See Notes to Condensed Consolidated Financial Statements

   

   

 

 9 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

   

 

   

Nine months ended
September 30,

   

2013

   

   

2012

   

CASH FLOWS FROM OPERATING ACTIVITIES

   

   

   

      

   

Consolidated net income (loss)

$

(5,699

   

$

13,261

      

Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:

   

   

   

   

   

   

   

Depreciation and amortization

   

46,653

      

   

   

47,843

      

Amortization of debt premium

   

(114

   

   

(72

Amortization of debt issuance costs

   

6,841

      

   

   

2,235

      

(Gain) loss on property, plant and equipment

   

(37

   

   

415

      

Impairment of long-lived assets

   

0

   

   

   

5,434

      

Earnings from unconsolidated joint venture, net of dividends received

   

51

      

   

   

(33

Deferred income tax benefit

   

(2,737

   

   

(6,172

Share-based compensation

   

6,362

      

   

   

5,245

      

Decrease (increase) in:

   

   

   

   

   

   

   

Accounts receivable

   

(18,737

   

   

(23,059

Inventories of products, materials and supplies

   

25,538

   

   

   

53,056

      

Other assets

   

5,772

   

   

   

(721

Increase (decrease) in:

   

   

   

   

   

   

   

Accounts payable-trade

   

(8,081

   

   

7,909

      

Other payables and accruals

   

(12,334

   

   

(8,768

Other long-term liabilities

   

3,304

      

   

   

(1,554

Due to related party

   

11,305

      

   

   

7,169

      

Net cash provided by operating activities

   

58,087

   

   

   

102,188

      

CASH FLOWS FROM INVESTING ACTIVITIES

   

   

   

   

   

   

   

Purchase of property, plant and equipment

   

(57,922

   

   

(42,436

Purchase of software and other intangibles

   

(3,106

   

   

(1,789

Settlement of net investment hedge

   

(2,490

   

   

1,648

      

Net cash used in investing activities

   

(63,518

   

   

(42,577

CASH FLOWS FROM FINANCING ACTIVITIES

   

   

   

   

   

   

   

Proceeds from debt

   

40,000

      

   

   

101,250

      

Repayments of debt

   

(136,875

   

   

(45,626

Capital lease payments

   

(950

   

   

0

      

Contribution from noncontrolling interest

   

30,216

      

   

   

0

      

Proceeds from the exercise of stock options

   

310

      

   

   

820

      

Debt issuance costs

   

(4,794

   

   

(3,156

Net cash provided by (used in) financing activities

   

(72,093

   

   

53,288

      

Effect of exchange rate differences on cash

   

(1,012

   

   

793

      

Net increase (decrease) in cash and cash equivalents

   

(78,536

   

   

113,692

      

Cash and cash equivalents, beginning of period

   

223,166

      

   

   

88,579

      

Cash and cash equivalents, end of period

$

144,630

      

   

$

202,271

      

Supplemental disclosures:

   

   

   

   

   

   

   

Cash paid during the period for income taxes, net of refunds received

$

7,397

      

   

$

12,695

      

Cash paid during the period for interest, net of capitalized interest

$

24,207

      

   

$

23,854

      

Capitalized interest

$

2,951

      

   

$

1,877

      

Supplemental non-cash disclosures:

   

   

   

   

   

   

   

Capital accruals

$

7,170

      

   

$

2,715

      

Capital lease liability included in accounts payable

$

1,950

      

   

$

0

      

See Notes to Condensed Consolidated Financial Statements

   

   

 

 10 


   

KRATON PERFORMANCE POLYMERS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Description of our Business. We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability. 

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products such as disposable diapers and the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms. We believe the versatility of Cariflex provides opportunities for new, high-margin applications.

We have a portfolio of innovations at various stages of development and commercialization, including

 

·

polyvinyl chloride alternatives for wire and cable, and medical applications;

 

·

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

 

·

our NEXAR family of membrane polymers for water filtration, heating, ventilation, air conditioning and breathable fabrics; and

 

·

synthetic cement formulations and other oilfield applications.

We manufacture our polymers at five manufacturing facilities globally, including our flagship facility in Belpre, Ohio, as well as facilities in Germany, France, Brazil and Japan. The facility in Japan is operated by an unconsolidated manufacturing joint venture. The terms “Kraton,” “our company,” “we,” “our,” “ours” and “us” as used in this report refer collectively to Kraton Performance Polymers, Inc. and its consolidated subsidiaries.

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements presented herein are for us and our consolidated subsidiaries, each of which is a wholly-owned subsidiary, except our 50% investment in our joint venture, Kraton Formosa Polymers Corporation (“KFPC”), located in Mailiao, Taiwan. KFPC is a variable interest entity for which we have determined that we are the primary beneficiary and, therefore, have consolidated into our financial statements. Our 50% investment in our joint venture located in Kashima, Japan is accounted for under the equity method of accounting. All significant intercompany transactions have been eliminated. These interim financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012 and reflect all normal recurring adjustments that are, in the opinion of management, necessary to present fairly our results of operations and financial position. Amounts reported in our Condensed Consolidated Statements of Operations are not necessarily indicative of amounts expected for the respective annual periods or any other interim period, in particular due to the effect of seasonal changes and weather conditions that typically affect our sales into our Paving and Roofing end use market.

 

 11 


   

Our significant accounting policies have been disclosed in Note 1 Description of Business, Basis of Presentation and Significant Accounting Policies in our most recent Annual Report on Form 10-K. There have been no changes to the policies disclosed therein. The accompanying unaudited condensed consolidated financial statements we present in this report have been prepared in accordance with those policies.

Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant items subject to such estimates and assumptions include

 

·

the useful lives of fixed assets;

 

·

allowances for doubtful accounts and sales returns;

 

·

the valuation of derivatives, deferred tax assets, property, plant and equipment, inventory, investments and share-based compensation; and

 

·

liabilities for employee benefit obligations, asset retirement obligations (“ARO”), income tax uncertainties and other contingencies.

Income Tax in Interim Periods. We conduct operations in separate legal entities in different jurisdictions. As a result, income tax amounts are reflected in these condensed consolidated financial statements for each of those jurisdictions. Tax laws and tax rates vary substantially in these jurisdictions and are subject to change based on the political and economic climate in those countries. We file our tax returns in accordance with our interpretations of each jurisdiction’s tax laws. We record our tax provision or benefit on an interim basis using the estimated annual effective tax rate. This rate is applied to the current period ordinary income or loss to determine the income tax provision or benefit allocated to the interim period.

Losses from jurisdictions for which no benefit can be realized and the income tax effects of unusual and infrequent items are excluded from the estimated annual effective tax rate. Valuation allowances are provided against the future tax benefits that arise from the losses in jurisdictions for which no benefit can be realized. The effects of unusual and infrequent items are recognized in the impacted interim period as discrete items.

The estimated annual effective tax rate may be significantly affected by nondeductible expenses and by our projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period during which such estimates are revised.

We have established valuation allowances against a variety of deferred tax assets, including net operating loss carryforwards, foreign tax credits and other income tax credits. Valuation allowances take into consideration our ability to realize these deferred tax assets and reduce the value of such assets to the amount that is deemed more likely than not to be recoverable. Our ability to realize these deferred tax assets is dependent on achieving our forecast of future taxable operating income over an extended period of time. We review our forecast in relation to actual results and expected trends on a quarterly basis. If we fail to achieve our operating income targets, we may change our assessment regarding the recoverability of our net deferred tax assets and such change could result in a valuation allowance being recorded against some or all of our net deferred tax assets. A change in our valuation allowance would impact our income tax expense/benefit and our stockholders’ equity and could have a significant impact on our results of operations or financial condition in future periods.

   

 

 12 


   

2. New Accounting Pronouncements

Adoption of Accounting Standards

We have implemented all new accounting pronouncements that are in effect and that management believes would materially affect our financial statements. Management does not believe that there are any other new accounting pronouncements that have been issued that may have a material impact on our financial position or results of operations.

   

3. Share-Based Compensation

We account for share-based awards under the provisions of ASC 718, “Compensation—Stock Compensation.” Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award and we expense these costs using the straight-line method over the requisite service period. Share-based compensation expense was $1.8 million and $1.5 million for the three months ended September 30, 2013 and 2012, respectively, and $6.4 million and $5.2 million for the nine months ended September 30, 2013 and 2012, respectively. We have historically recorded these costs in selling, general and administrative expenses; however, beginning in the second quarter of 2013, a portion of these costs were recorded in cost of goods sold and research and development expenses.

   

4. Detail of Certain Balance Sheet Accounts

   

   

 

   

September 30,
2013

   

   

December 31,
2012

   

   

(In thousands)

   

Inventories of products:

   

   

   

   

   

   

   

Finished products

$

229,651

      

   

$

260,510

      

Work in progress

   

2,367

      

   

   

6,759

      

Raw materials

   

81,757

      

   

   

73,054

      

Total inventories of products

$

313,775

      

   

$

340,323

      

Other payables and accruals:

   

   

   

   

   

   

   

Employee related

$

12,704

      

   

$

13,423

      

Income taxes payable

   

2,343

      

   

   

3,638

      

Other

   

24,640

      

   

   

33,917

      

Total other payables and accruals

$

39,687

      

   

$

50,978

      

Other long-term liabilities:

   

   

   

   

   

   

   

Pension and other postretirement benefits

$

84,889

      

   

$

84,005

      

Other

   

18,162

      

   

   

15,941

      

Total other long-term liabilities

$

103,051

      

   

$

99,946

      

Accumulated other comprehensive loss:

   

   

   

   

   

   

   

Foreign currency translation adjustments

$

23,221

      

   

$

26,956

      

Net unrealized loss on interest rate swaps

   

0

      

   

   

(837

Net unrealized loss on net investment hedge

   

(1,926

   

   

(1,436

Pension liability

   

(59,193

   

   

(59,193

Total accumulated other comprehensive loss

$

(37,898

   

$

(34,510

   

   

 

 13 


   

5. Earnings Per Share (“EPS”)

Basic EPS is computed by dividing net income attributable to Kraton by the weighted-average number of shares outstanding during the period.

Diluted EPS is computed by dividing net income attributable to Kraton by the diluted weighted-average number of shares outstanding during the period and, accordingly, reflects the potential dilution that could occur if securities or other agreements to issue common stock, such as stock options, were exercised, settled or converted into common stock and were dilutive. The diluted weighted-average number of shares used in our diluted EPS calculation is determined using the treasury stock method.

Unvested awards of share-based payments with rights to receive dividends or dividend equivalents, such as our restricted stock awards, are considered to be participating securities, and therefore, the two-class method is used for purposes of calculating EPS. Under the two-class method, a portion of net income is allocated to these participating securities and is excluded from the calculation of EPS allocated to common stock. Our restricted stock awards are subject to forfeiture and restrictions on transfer until vested and have identical voting, income and distribution rights to the unrestricted common shares outstanding.

The computation of diluted EPS excludes the effect of the potential exercise of stock options that are anti-dilutive. The number of stock options excluded from the computation was 1,643,950 and 757,687 for the three months ended September 30, 2013 and 2012, and 1,643,950 and 737,033 for the nine months ended September 30, 2013 and 2012, respectively. For the three months ended September 30, 2013, the weighted average restricted share units and performance share units of 57,591 and 67,585, respectively, and 51,106 and 51,988 for the nine months ended September 30, 2013, respectively, are not included as a component of diluted EPS as they are anti-dilutive.

The effects of share-based compensation awards on the diluted weighted-average number of shares outstanding used in calculating diluted EPS are as follows:

   

 

   

Three months ended
September 30, 2013

   

   

Three months ended
September 30, 2012

   

   

Net
Loss
Attributable
to Kraton

   

   

Weighted
Average
Shares
Outstanding

   

   

Loss
Per
Share

   

   

Net
Loss
Attributable
to Kraton

   

   

Weighted
Average
Shares
Outstanding

   

   

Loss
Per
Share

   

   

(In thousands, except per share data)

   

   

(In thousands, except per share data)

   

Basic:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

As reported

$

(5,598

)

   

   

32,528

   

   

   

   

   

   

$

(15,499

)

   

   

32,251

   

   

   

   

   

Amounts allocated to unvested restricted shares

   

78

   

   

   

(455

)

   

   

   

   

   

   

148

   

   

   

(308

)

   

   

   

   

Amounts available to common stockholders

   

(5,520

)

   

   

32,073

   

   

$

(0.17

)

   

   

(15,351

)

   

   

31,943

   

   

$

(0.48

)

Diluted:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Amounts allocated to unvested restricted shares

   

(78

)

   

   

455

   

   

   

   

   

   

   

(148

)

   

   

308

   

   

   

   

   

Non participating share units

   

0

   

   

   

0

   

   

   

   

   

   

   

0

   

   

   

0

   

   

   

   

   

Stock options added under the treasury stock method

   

0

   

   

   

0

   

   

   

   

   

   

   

0

   

   

   

0

   

   

   

   

   

Amounts reallocated to unvested restricted shares

   

78

   

   

   

(455

)

   

   

   

   

   

   

148

   

   

   

(308

)

   

   

   

   

Amounts available to stockholders and assumed conversions

$

(5,520

)

   

   

32,073

   

   

$

(0.17

)

   

$

(15,351

)

   

   

31,943

   

   

$

(0.48

)

 

 14 


   

   

 

   

Nine months ended
September 30, 2013

   

   

Nine months ended
September 30, 2012

   

   

Net
Loss
Attributable
to Kraton

   

   

Weighted
Average
Shares
Outstanding

   

   

Loss
Per
Share

   

   

Net
Income
Attributable
to Kraton

   

   

Weighted
Average
Shares
Outstanding

   

   

Earnings
Per
Share

   

   

(In thousands, except per share data)

   

   

(In thousands, except per share data)

   

Basic:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

As reported

$

(5,517

)

   

   

32,471

   

   

   

   

   

   

$

13,261

   

   

   

32,210

   

   

   

   

   

Amounts allocated to unvested restricted shares

   

68

   

   

   

(402

)

   

   

   

   

   

   

(117

)

   

   

(283

)

   

   

   

   

Amounts available to common stockholders

   

(5,449

)

   

   

32,069

   

   

$

(0.17

)

   

   

13,144

   

   

   

31,927

   

   

$

0.41

   

Diluted:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Amounts allocated to unvested restricted shares

   

(68

)

   

   

402

   

   

   

   

   

   

   

117

   

   

   

283

   

   

   

   

   

Non participating share units

   

0

   

   

   

0

   

   

   

   

   

   

   

0

   

   

   

29

   

   

   

   

   

Stock options added under the treasury stock method

   

0

   

   

   

0

   

   

   

   

   

   

   

0

   

   

   

246

   

   

   

   

   

Amounts reallocated to unvested restricted shares

   

68

   

   

   

(402

)

   

   

   

   

   

   

(116

)

   

   

(283

)

   

   

   

   

Amounts available to stockholders and assumed conversions

$

(5,449

)

   

   

32,069

   

   

$

(0.17

)

   

$

13,145

   

   

   

32,202

   

   

$

0.41

   

   

   

6. Long-Term Debt

Long-term debt consists of the following:

   

 

   

September 30,
2013

   

      

December 31,
2012

   

   

(In thousands)

   

Term loans

$

0

      

      

$

96,875

      

6.75% unsecured notes

   

351,028

      

      

   

351,142

      

Total long-term debt

   

351,028

      

      

   

448,017

      

Less current portion of long-term debt

   

0

      

      

   

15,074

      

Long-term debt, less current portion

$

351,028

      

      

$

432,943

      

Senior Secured Credit Facilities. In March 2013, we entered into an asset-based revolving credit facility consisting of a $150.0 million U.S. senior secured revolving credit facility and a $100.0 million Dutch senior secured revolving credit facility (the “Senior Secured Credit Facilities”). The Senior Secured Credit Facilities replaced our then existing senior secured credit facility, and we repaid in full all outstanding amounts payable under the previously existing indebtedness. Borrowing under the Senior Secured Credit Facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security.

We may request up to an aggregate of $100.0 million of additional revolving facility commitments of which up to an aggregate of $40.0 million may be additional Dutch revolving facility commitments, provided that we satisfy additional conditions described in the Senior Secured Credit Facilities, and provided further that the U.S. revolver commitment is at least 60% of the commitments after giving effect to such increase.

Kraton Polymers U.S. LLC and Kraton Polymers Nederland B.V. are the borrowers under the Senior Secured Credit Facilities, and Kraton Performance Polymers, Inc., Kraton Polymers LLC, Elastomers Holdings LLC and Kraton Polymers Capital Corporation are guarantors. The Senior Secured Credit Facilities are secured by receivables and inventory. The Senior Secured Credit Facilities terminate on March 27, 2018; however, we may from time to time request that the lenders extend the maturity of their commitments. Availability under the Senior Secured Credit Facilities is limited to the lesser of the borrowing base and total commitments (less certain reserves).

 

 15 


   

U.S. borrowings under the Senior Secured Credit Facilities (other than swingline loans) bear interest at a rate equal to, at the applicable borrower’s option, either (a) a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% and (3) LIBOR plus 1.0%, or (b) a rate based on LIBOR, in each case plus an applicable margin. U.S. swingline loans shall bear interest at a base rate determined by reference to the greater of (1) the prime rate of Bank of America, N.A., (2) the federal funds rate plus 0.50% or (3) LIBOR plus 1.0%, in each case plus an applicable margin.

Dutch borrowings under the Senior Secured Credit Facilities bear interest at a rate equal to, at the applicable borrower’s option, either (a) a fluctuating rate, with respect to Euros, Pounds Sterling and Dollars outside of the U.S. and Canada, equal to the rate announced by the European Central Bank and used as a base rate by the local branch of Bank of America in the jurisdiction in which such currency is funded, or (b) a rate based on LIBOR, in each case plus an applicable margin.

The applicable margin is subject to a minimum of 0.5% and a maximum of 1.0% with respect to U.S. base rate loans, and a minimum of 1.5% and maximum of 2.0% for foreign base rate borrowings and LIBOR loans and is subject to adjustment based on the borrowers’ excess availability of the applicable facility for the most recent fiscal quarter.

In addition to paying interest on outstanding principal amounts under the Senior Secured Credit Facilities, the borrowers will be required to pay a commitment fee in respect of the unutilized commitments at an annual rate of 0.375%.

The Senior Secured Credit Facilities contain a financial covenant that if either (a) excess availability is less than the greater of (i) 12.5% of the lesser of the commitments and the borrowing base and (ii) $31,250,000 or (b) U.S. availability is less than the greater of (i) 12.5% of the lesser of the U.S. commitments and U.S. borrowing base and (ii) $18,750,000, then following such event, Kraton and its restricted subsidiaries must maintain a fixed charge coverage ratio of at least 1.0 to 1.0. The Senior Secured Credit Facilities contain certain customary events of default, including, without limitation, a failure to make payments under the facility, cross-default and cross-judgment default, certain bankruptcy events and certain change of control events.

As of September 30, 2013, our available borrowing capacity was $187.3 million of which $0.0 million was drawn. As of the date of this filing, our available borrowing capacity was $196.4 million, of which $0.0 million was drawn.

6.75% Senior Notes due 2019. Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019 pursuant to an indenture, dated February 11, 2011 ($250.0 million senior notes) and supplemental indenture thereto dated March 20, 2012 ($100.0 million senior notes). The indenture provides that the notes are general unsecured, senior obligations and will be unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year.

Debt Maturities. The remaining principal payments on our outstanding total debt as of September 30, 2013, are as follows:

   

 

   

Principal
Payments

   

   

(In thousands)

   

December 31:

   

   

   

2019

   

350,000

      

Total debt

$

350,000

      

See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for fair value information related to our long-term debt.

   

   

   

 

 16 


   

7. Debt Issuance Costs

We capitalize the debt issuance costs related to issuing long-term debt and amortize these costs using the effective interest method, except for costs related to revolving debt, which are amortized using the straight-line method. We had net debt issuance costs of $11.9 million and $13.9 million (of which $2.2 million and $3.1 million were included in other current assets) as of September 30, 2013 and December 31, 2012, respectively. In connection with the March 2013 refinancing of our indebtedness, we charged to interest expense $5.0 million of unamortized debt issuance costs related to our previously existing indebtedness and we capitalized $4.8 million of debt issuance costs related to our new indebtedness. We amortized $0.5 million and $0.7 million of debt issuance costs for the three months ended September 30, 2013 and 2012, respectively, and $1.8 million (which excludes the $5.0 million of accelerated amortization) and $2.2 million of debt issuance costs for the nine months ended September 30, 2013 and 2012, respectively.

   

   

8. Fair Value Measurements, Financial Instruments and Credit Risk

ASC 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 requires entities to, among other things, maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions.

In accordance with ASC 820, these two types of inputs have created the following fair value hierarchy:

 

·

Level 1—Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets;

 

·

Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

·

Quoted prices for similar assets or liabilities in active markets

 

·

Quoted prices for identical or similar assets or liabilities in markets that are not active

 

·

Inputs other than quoted prices that are observable for the asset or liability

 

·

Inputs that are derived principally from or corroborated by observable market data by correlation or other means; and

 

·

Level 3—Inputs that are unobservable and reflect our assumptions used in pricing the asset or liability based on the best information available under the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

Recurring Fair Value Measurements. The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2013 and December 31, 2012. These financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Our assessment of the significance of a particular input to the fair value measurement requires judgment, which judgment may affect the valuation of their fair value and their placement within the fair value hierarchy levels.

 

 17 


   

   

 

   

Balance Sheet Location

   

   

September 30,
2013

   

   

Fair Value Measurements at Reporting Date Using

   

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

   

   

Significant
Other
Observable
Inputs
(Level 2)

   

   

Significant
Unobservable
Inputs
(Level 3)

   

   

   

   

   

   

   

   

(In thousands)

   

   

   

   

Retirement plan asset—noncurrent

Other long-term assets

   

   

   

1,672

   

   

   

1,672

   

   

   

0

   

   

   

0

   

Derivative liability—current

Other payables and accruals

   

   

   

(22

)

   

   

0

   

   

   

(22

)

   

   

0

   

Total

   

   

   

$

1,650

   

   

$

1,672

   

   

$

(22

)

   

$

0

   

   

 

   

Balance Sheet Location

   

   

December 31,
2012

   

   

Fair Value Measurements at Reporting Date Using

   

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

   

   

Significant
Other
Observable
Inputs
(Level 2)

   

   

Significant
Unobservable
Inputs
(Level 3)

   

   

   

   

   

   

   

   

   

(In thousands)

   

   

   

   

   

Derivative asset—current

Other current assets

   

   

$

34

   

   

$

0

   

   

$

34

   

   

$

0

   

Retirement plan asset—noncurrent

Other long-term assets

   

   

   

860

   

   

   

860

   

   

   

0

   

   

   

0

   

Derivative liability—current

Other payables and accruals

   

   

   

(578

)

   

   

0

   

   

   

(578

)

   

   

0

   

Derivative liability—noncurrent

Other long-term liabilities

   

   

   

(258

)

   

   

0

   

   

   

(258

)

   

   

0

   

Total

   

   

   

$

58

   

   

$

860

   

   

$

(802

)

   

$

0

   

The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. We seek to minimize this risk by limiting our counterparties to major financial institutions with acceptable credit ratings and by monitoring the total value of positions with individual counterparties. In the event of a default by one of our counterparties, we may not receive payments provided for under the terms of our derivatives.

The following table presents the carrying values and approximate fair values of our long-term debt.

   

 

   

September 30, 2013

   

      

December 31, 2012

   

   

Carrying
Value

   

      

Fair
Value

   

      

Carrying
Value

   

      

Fair
Value

   

   

(In thousands)

   

Term loans

$

0

      

      

$

0

      

      

$

96,875

      

      

$

96,875

      

6.75% unsecured notes

$

351,028

      

      

$

358,810

      

      

$

351,142

      

      

$

364,000

      

The term loans are variable interest rate instruments, and as such, the fair value approximates their carrying value.

Financial Instruments

Interest Rate Swap Agreements. Periodically, we enter into interest rate swap agreements to hedge or otherwise protect against interest rate fluctuations on a portion of our variable rate debt. These interest rate swap agreements are designated as cash flow hedges on our exposure to the variability of future cash flows.

In June 2011, we entered into a $75.0 million notional amount interest rate swap agreement with respect to a portion of our outstanding term loans. This agreement was effective on July 15, 2011 and was set to expire on June 15, 2014. However, on March 27, 2013, in connection with the refinancing of our credit facility, we terminated and settled the interest rate swap agreement, and as a result, recognized $0.7 million of interest expense for the three months ended March 31, 2013. We recorded an unrealized loss of $0.1 million in accumulated other comprehensive loss related to the effective portion of this interest rate swap agreement for the three months ended March 31, 2012.

 

 18 


   

Fair Value Hedges. In April 2012, we entered into a series of non-deliverable forward contracts to reduce our exposure to fluctuations in the Canadian dollar (“CAD”) against the U.S. dollar in connection with the funding of certain capital expenditures. These non-deliverable forward contracts qualified for hedge accounting and were designated as fair value hedges in accordance with ASC 815-25 “Fair Value Hedges.” The only non-deliverable forward contract outstanding as of September 30, 2013 had a notional amount of CAD $1.6 million with a settlement date of October 8, 2013. This hedge was effective in offsetting our exposure to the CAD, and therefore the $0.1 million gain on the hedge was offset by the $0.1 million loss on the exposure associated with the funding of our semi-works facility for the three months ended September 30, 2013. There was no net impact for the nine months ended September 30, 2013. Similarly, for the three months ended September 30, 2012, the $0.1 million gain on the hedge was offset by the $0.1 million loss on the exposure to the CAD and for the nine months ended September 30, 2012 the $0.1 million loss on the hedge was offset by the $0.1 million gain on the exposure to the CAD.

Net Investment Hedges. During 2012, we entered into a series of non-deliverable forward and foreign currency option contracts to protect our net investment in our European subsidiaries against adverse changes in exchange rates by fixing the U.S. dollar/Euro exchange rate. The notional amounts of these contracts ranged from €50.0 million to €100.0 million with all contracts expiring after thirty days. In June 2013, we entered into a €11.6 million notional amount non-deliverable forward contract to protect our net investment in our subsidiary in Taiwan against adverse changes in exchange rates by fixing the New Taiwan Dollar/Euro exchange rate. These contracts qualify for hedge accounting and were designated as net investment hedges in accordance with ASC 815-35 “Net Investment Hedges.” We recorded in accumulated other comprehensive loss an aggregate $0.5 million loss related to the settlement of the effective portion of these contracts during the nine months ended September 30, 2013.We recorded in accumulated other comprehensive loss an aggregate $0.6 million gain related to the settlement of the effective portion of these contracts during the nine months ended September 30, 2012.

Foreign Currency Hedges. Periodically, we enter into foreign currency agreements to hedge or otherwise protect against fluctuations in foreign currency exchange rates. These agreements typically do not qualify for hedge accounting and gains/losses resulting from both the up-front premiums and/or settlement of the hedges at expiration of the agreements are recognized in the period in which they are incurred. During the nine months ended September 30, 2013 and 2012, we entered into a series of foreign currency option and forward contracts to reduce our exposure to exchange rate volatility. The contracts were structured such that the underlying foreign currency exchange gains/losses would be offset by the mark-to-market impact of the hedging instruments and reduce the impact of foreign currency exchange movements throughout the period. These contracts did not qualify for hedge accounting. For the three months ended September 30, 2013 and 2012, we settled these hedges and recorded an aggregate gain of $0.3 million and a gain of $0.1 million, respectively. For the nine months ended September 30, 2013 and 2012, we recorded an aggregate loss of $1.5 million and a gain of $1.2 million, respectively. In all periods, the gains or losses on settlement of these hedges offset the underlying foreign currency exchange gains and losses recorded in cost of goods sold.

Credit Risk

We analyze the counterparties’ financial condition prior to extending credit and we establish credit limits and monitor the appropriateness of those limits on an ongoing basis. We also obtain cash, letters of credit or other acceptable forms of security from customers to provide credit support, where appropriate, based on our financial analysis of the customer and the contractual terms and conditions applicable to each transaction.

   

9. Income Taxes

Our income tax provision was $2.0 million expense and $1.6 million benefit for the three months ended September 30, 2013 and 2012, and $4.4 million expense for both the nine months ended September 30, 2013 and 2012, respectively. Our effective tax rate was 52.8% expense and 9.6% benefit for the three months ended September 30, 2013 and 2012, and 329.5% and 24.7% expense for the nine months ended September 30, 2013 and 2012, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and the change in our valuation allowance.

   

   

 

 19 


   

As of September 30, 2013 and December 31, 2012, a valuation allowance of $98.3 million and $90.4 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We record a valuation allowance when it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. We increased our valuation allowance by $3.6 million for the three months ended September 30, 2013, of which $3.5 million represents current period net operating losses and $0.1 million represents changes in other comprehensive income (loss).  We increased our valuation allowance by $9.8 million for the three months ended September 30, 2012, due to net operating losses. We increased our valuation allowance by $7.9 million for the nine months ended September 30, 2013, of which $8.0 million represents current period net operating losses, partially offset by $0.1 million, which represents changes in other comprehensive income (loss). We increased our valuation allowance by $9.6 million for the nine months ended September 30, 2012, due to net operating losses. Excluding the change in our valuation allowance, our effective tax rate would have been 38.3% and 66.4% benefit for the three months ended September 30, 2013 and 2012, respectively, and a 276.9% and 29.1% benefit for the nine months ended September 30, 2013 and 2012, respectively, primarily due to the mix of pre-tax income or loss earned in certain tax jurisdictions.

As of September 30, 2013 and December 31, 2012, we had total unrecognized tax benefits of $6.9 million and $5.1 million, respectively, related to uncertain foreign tax positions, all of which, if recognized, would impact our effective tax rate. During the three months ended September 30, 2013 and 2012, we had an increase in uncertain tax positions of $0.7 million and $0.4 million, respectively, and $1.8 million and $1.5 million during the nine months ended September 30, 2013 and 2012, respectively, primarily related to uncertain tax positions in Europe. We recorded interest and penalties related to unrecognized tax benefits within our provision for income taxes. We believe that no current tax positions that have resulted in unrecognized tax benefits will significantly increase or decrease within one year.

We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. For our U.S. federal income tax returns, the statute of limitations has expired through the tax year ended December 31, 2003. As a result of net operating loss carryforwards from 2004, the statute of limitations remains open for all years subsequent to 2003. In addition, open tax years for state and foreign jurisdictions remain subject to examination.

   

10. Commitments and Contingencies

Legal Proceedings. We received notice from the tax authorities in Brazil assessing R$5.9 million in connection with tax credits that were generated from the purchase of certain goods. The credits were subsequently applied against taxes owed. The tax authorities assert that the goods purchased were not eligible to earn a credit. We have appealed this assessment and contend that the tax credits were earned. While the outcome of this proceeding cannot be predicted with certainty, we do not expect this matter to have a material adverse effect upon our financial position, results of operations or cash flows.

We and certain of our subsidiaries, from time to time, are parties to various other legal proceedings, claims and disputes that have arisen in the ordinary course of business. These claims may involve significant amounts, some of which would not be covered by insurance. A substantial settlement payment or judgment in excess of our accruals could have a material adverse effect on our financial position, results of operations or cash flows. While the outcome of these proceedings cannot be predicted with certainty, our management does not expect any of these existing matters, individually or in the aggregate, to have a material adverse effect upon our financial position, results of operations or cash flows.

Asset Retirement Obligations.

The changes in the aggregate carrying amount of our ARO liability are as follows:

   

 

   

ARO Liability

   

   

(In thousands)

   

Balance at December 31, 2012

$

9,837

      

Accretion expense

   

377

      

Foreign currency translation

   

93

   

Balance at September 30, 2013

$

10,307

      

 

 20 


   

There have been no other material changes to our Commitments and Contingencies disclosed in our most recently filed Annual Report on Form 10-K.

   

11. Employee Benefits

Retirement Plans.

The components of net periodic benefit cost related to U.S. pension benefits are as follows:

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

   

(in thousands)

   

   

(in thousands)

   

Service cost

$

828

   

   

$

795

   

   

$

2,528

   

   

$

2,385

   

Interest cost

   

1,384

   

   

   

1,394

   

   

   

4,179

   

   

   

4,185

   

Expected return on plan assets

   

(1,654

)

   

   

(1,464

)

   

   

(4,959

)

   

   

(4,455

)

Amortization of prior service cost

   

880

   

   

   

683

   

   

   

2,745

   

   

   

2,048

   

Net periodic benefit cost

$

1,438

   

   

$

1,408

   

   

$

4,493

   

   

$

4,163

   

We made contributions of $4.8 million and $6.8 million to our pension plan in the nine months ended September 30, 2013 and 2012, respectively.

The components of net periodic benefit cost related to other post-retirement benefits are as follows:

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

   

(in thousands)

   

   

(in thousands)

   

Service cost

$

130

   

   

$

127

   

   

$

420

   

   

$

383

   

Interest cost

   

285

   

   

   

305

   

   

   

870

   

   

   

915

   

Amortization of prior service cost

   

161

   

   

   

150

   

   

   

525

   

   

   

450

   

Net periodic benefit cost

$

576

   

   

$

582

   

   

$

1,815

   

   

$

1,748

   

   

 

 21 


   

12. Industry Segment and Foreign Operations

We operate in one segment for the manufacturing and marketing of engineered polymers. In accordance with the provisions of ASC 280, “Segment Reporting,” our chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Since we operate in one segment and in one group of similar products, all financial segment and product line information required by ASC 280 can be found in the condensed consolidated financial statements.

We manufacture our products along the following primary product lines based upon polymer chemistry and process technologies:

 

·

un-hydrogenated SBCs (“USBCs”);

 

·

hydrogenated SBCs (“HSBCs”);

 

·

Cariflex isoprene rubber and isoprene rubber latex; and

 

·

compounds.

Sales revenue for our four primary product lines is as follows:

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

   

(in thousands)

   

   

(in thousands)

   

USBCs

$

192,714

   

   

$

208,119

   

   

$

582,030

   

   

$

670,219

   

HSBCs

   

98,572

   

   

   

103,400

   

   

   

311,603

   

   

   

353,921

   

Cariflex

   

28,231

   

   

   

24,193

   

   

   

84,504

   

   

   

76,643

   

Compounds

   

7,187

   

   

   

6,685

   

   

   

22,635

   

   

   

23,799

   

Other

   

405

   

   

   

238

   

   

   

987

   

   

   

2,122

   

   

$

327,109

   

   

$

342,635

   

   

$

1,001,759

   

   

$

1,126,704

   

For geographic reporting, sales revenue is attributed to the geographic location in which the customers’ facilities are located. Long-lived assets consist primarily of property, plant and equipment, which are attributed to the geographic location in which they are located and are presented at historical cost.

 

 22 


   

Sales revenue and long-lived assets by geographic region are as follows:

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

   

2012

   

   

2013

   

   

2012

   

   

(in thousands)

   

   

(in thousands)

   

Sales revenue:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

United States

$

99,726

   

   

$

103,114

   

   

$

313,963

   

   

$

375,453

   

Germany

   

49,263

   

   

   

52,078

   

   

   

134,948

   

   

   

152,277

   

Japan

   

20,341

   

   

   

23,561

   

   

   

57,472

   

   

   

64,757

   

China

   

17,872

   

   

   

19,324

   

   

   

54,065

   

   

   

59,241

   

Brazil

   

14,701

   

   

   

11,807

   

   

   

41,582

   

   

   

37,627

   

France

   

12,534

   

   

   

12,361

   

   

   

35,729

   

   

   

39,188

   

Belgium

   

9,751

   

   

   

10,745

   

   

   

32,865

   

   

   

36,340

   

Italy

   

9,424

   

   

   

10,445

   

   

   

32,822

   

   

   

34,945

   

Thailand

   

10,457

   

   

   

10,750

   

   

   

30,621

   

   

   

32,382

   

United Kingdom

   

8,011

   

   

   

7,411

   

   

   

28,770

   

   

   

30,499

   

Netherlands

   

6,118

   

   

   

6,076

   

   

   

22,332

   

   

   

26,867

   

Malaysia

   

6,664

   

   

   

2,673

   

   

   

19,802

   

   

   

12,789

   

Turkey

   

7,743

   

   

   

5,293

   

   

   

19,333

   

   

   

24,071

   

Mexico

   

4,460

   

   

   

3,443

   

   

   

14,143

   

   

   

9,891

   

Sweden

   

4,333

   

   

   

5,361

   

   

   

13,905

   

   

   

14,067

   

Taiwan

   

3,649

   

   

   

4,744

   

   

   

13,588

   

   

   

14,784

   

Canada

   

3,585

   

   

   

4,170

   

   

   

13,264

   

   

   

14,769

   

Argentina

   

3,798

   

   

   

3,371

   

   

   

12,709

   

   

   

11,144

   

Austria

   

3,699

   

   

   

4,467

   

   

   

9,769

   

   

   

14,622

   

South Korea

   

2,532

   

   

   

4,068

   

   

   

9,691

   

   

   

12,457

   

Poland

   

5,589

   

   

   

6,758

   

   

   

9,400

   

   

   

16,879

   

Australia

   

507

   

   

   

4,348

   

   

   

7,492

   

   

   

13,128

   

All other countries

   

22,352

   

   

   

26,267

   

   

   

73,494

   

   

   

78,527

   

   

$

327,109

   

   

$

342,635

   

   

$

1,001,759

   

   

$

1,126,704

   

   

   

 

   

September 30,
2013

   

   

December 31,
2012

   

   

(In thousands)

   

Long-lived assets, at cost:

   

   

   

United States

$

438,137

   

   

$

411,969

   

France

   

122,061

   

   

   

118,275

   

Brazil

   

77,612

   

   

   

79,585

   

Germany

   

61,475

   

   

   

55,581

   

Netherlands

   

25,874

   

   

   

15,255

   

Taiwan

   

10,755

   

   

   

0

   

China

   

6,997

   

   

   

5,906

   

Japan

   

1,808

   

   

   

1,978

   

All other countries

   

4,477

   

   

   

4,435

   

   

$

749,196

   

   

$

692,984

   

   

   

 

 23 


   

13. Related Party Transactions

We own a 50% equity investment in a SBC manufacturing joint venture with JSR Corporation (“JSR”) under the name of Kraton JSR Elastomers K.K. (“KJE”) located in Kashima, Japan. We and JSR separately, but with equal rights, participate in distributions in the sales of the thermoplastic rubber produced by KJE.

The aggregate amounts of related-party transactions were as follows:

   

 

   

Three months ended
September 30,

   

      

Nine months ended
September 30,

   

   

2013

   

      

2012

   

      

2013

   

      

2012

   

   

(in thousands)

   

      

(in thousands)

   

Purchases from related party

$

15,215

      

      

$

8,518

      

      

$

37,940

      

      

$

39,188

      

Our due to related party is solely related to our commercial arrangement associated with KJE, which requires payment by each party within 150 days of invoice.

   

   

14. Variable Interest Entity

In February 2013, we executed definitive agreements providing for a 50/50 joint venture with Formosa Petrochemical Corporation (“FPCC”) to build, own and operate a 30 kiloton HSBC plant at FPCC’s petrochemical site in Mailiao, Taiwan. The joint venture company, Kraton Formosa Polymers Corporation (“KFPC”), is a Taiwan entity with each of Kraton and FPCC having equal representation on the board. Both Kraton and FPCC made an initial investment of approximately $15.2 million at inception, with an additional Kraton contribution of $15.0 million in August 2013. We have exclusive rights to purchase all production from KFPC. Additionally, we will be obligated to purchase a minimum volume each year, with the minimum obligation increasing over the first three years the plant is operational. As such, we have determined that we are the primary beneficiary of this variable interest entity and, therefore, have consolidated KFPC in our financial statements as of and for the nine months ended September 30, 2013 and have reflected FPCC’s ownership as a noncontrolling interest.

The following table summarizes the fair value of KFPC assets and liabilities as of February 27, 2013 recorded upon initial consolidation in our condensed consolidated balance sheet and the carrying amounts of such assets and liabilities as of September 30, 2013, before intercompany eliminations.

   

 

   

September 30,
2013

   

      

February 27,
2013

   

   

(In thousands)

   

Cash and cash equivalents

$

48,900

      

      

$

30,348

      

Other current assets

   

455

      

      

   

0

      

Property, plant and equipment

   

10,742

      

      

   

0

      

Intangible assets

   

10,257

      

      

   

0

      

Other long-term assets

   

320

      

      

   

0

   

Total assets

$

70,674

      

      

$

30,348

      

Current liabilities

   

2,882

      

      

   

0

      

Other long-term liabilities

   

7,138

      

      

   

0

   

Total liabilities

$

10,020

      

      

$

0

      

   

   

15. Supplemental Guarantor Information

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, (“the Issuers”), are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Performance Polymers, Inc. and Elastomers Holdings LLC, a U.S. holding company and wholly-owned subsidiary of Kraton Polymers LLC, collectively, (“the Guarantors”), fully and unconditionally guarantee on a joint and several basis, the Issuers’ obligations under the 6.75% senior notes. Our remaining subsidiaries are not guarantors of the 6.75% senior notes. We do not believe that separate financial statements and other disclosures concerning the guarantor subsidiaries would provide any additional information that would be material to investors in making an investment decision.

   

   

 

 24 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

September 30, 2013

(Unaudited)

(In thousands, except par value)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

ASSETS

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Current assets:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Cash and cash equivalents

$

0

      

      

$

0

      

   

$

10,454

      

   

$

134,176

      

      

$

0

      

   

$

144,630

      

Receivables, net of allowances of $414

   

0

      

      

   

10

      

   

   

45,923

      

   

   

96,953

      

      

   

0

      

   

   

142,886

      

Inventories of products

   

0

      

      

   

0

      

   

   

179,869

      

   

   

133,906

      

      

   

0

      

   

   

313,775

      

Inventories of materials and supplies

   

0

      

      

   

0

      

   

   

8,485

      

   

   

2,209

      

      

   

0

      

   

   

10,694

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

5,768

      

   

   

3,264

      

      

   

0

      

   

   

9,032

      

Other current assets

   

0

      

      

   

3,186

      

   

   

1,482

      

   

   

14,933

      

      

   

0

      

   

   

19,601

      

Total current assets

   

0

      

      

   

3,196

      

   

   

251,981

      

   

   

385,441

      

      

   

0

      

   

   

640,618

      

Property, plant and equipment, less accumulated depreciation of $346,587

   

0

      

      

   

49,525

      

   

   

231,383

      

   

   

121,701

      

      

   

0

      

   

   

402,609

      

Intangible assets, less accumulated amortization of $76,152

   

0

      

      

   

35,920

      

   

   

22,713

      

   

   

(186

      

   

0

      

   

   

58,447

      

Investment in consolidated subsidiaries

   

527,880

      

      

   

1,306,496

      

   

   

0

      

   

   

0

      

      

   

(1,834,376

)

   

   

0

      

Investment in unconsolidated joint venture

   

0

      

      

   

813

      

   

   

0

      

   

   

12,941

      

      

   

0

      

   

   

13,754

      

Debt issuance costs

   

0

      

      

   

6,319

      

   

   

2,018

      

   

   

1,419

      

      

   

0

      

   

   

9,756

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

0

      

   

   

617

      

      

   

0

      

   

   

617

      

Other long-term assets

   

0

      

      

   

1,619

      

   

   

552,087

      

   

   

117,763

      

      

   

(645,422

)

   

   

26,047

      

Total assets

$

527,880

      

      

$

1,403,888

      

   

$

1,060,182

      

   

$

639,696

      

      

$

(2,479,798

)

   

$

1,151,848

      

LIABILITIES AND STOCKHOLDERS’ AND MEMBER’S EQUITY

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Current liabilities:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Accounts payable-trade

   

0

      

      

   

99

      

   

   

35,354

      

   

   

57,740

      

      

   

0

      

   

   

93,193

      

Other payables and accruals

   

0

      

      

   

1,969

      

   

   

21,259

      

   

   

16,459

   

      

   

0

      

   

   

39,687

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

0

      

   

   

412

      

      

   

0

      

   

   

412

      

Due to related party

   

0

      

      

   

0

      

   

   

0

      

   

   

22,813

      

      

   

0

      

   

   

22,813

      

Total current liabilities

   

0

      

      

   

2,068

      

   

   

56,613

      

   

   

97,424

      

      

   

0

      

   

   

156,105

      

Long-term debt, net of current portion

   

0

      

      

   

351,028

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

351,028

      

Deferred income taxes

   

0

      

      

   

10,642

      

   

   

5,768

      

   

   

4,945

      

      

   

0

      

   

   

21,355

      

Other long-term liabilities

   

0

      

      

   

513,004

      

   

   

91,096

      

   

   

144,373

      

      

   

(645,422

)

   

   

103,051

      

Total liabilities

   

0

      

      

   

876,742

      

   

   

153,477

      

   

   

246,742

      

      

   

(645,422

)

   

   

631,539

      

Commitments and contingencies (note 10)

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Stockholders’ and member’s equity:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

   

0

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

0

      

Common stock, $0.01 par value; 500,000 shares authorized; 32,528 shares issued and outstanding

   

325

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

325

      

Additional paid in capital

   

361,627

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

361,627

      

Member’s equity

   

0

      

      

   

527,880

      

   

   

959,792

      

   

   

346,704

      

      

   

(1,834,376

)

   

   

0

      

Retained earnings

   

165,928

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

165,928

      

Accumulated other comprehensive income (loss)

   

0

      

      

   

(734

   

   

(53,087

   

   

15,923

      

      

   

0

      

   

   

(37,898

Kraton stockholders’ and member’s equity

   

527,880

      

      

   

527,146

      

   

   

906,705

      

   

   

362,627

      

      

   

(1,834,376

)

   

   

489,982

      

Noncontrolling interest

   

0

      

      

   

0

      

   

   

0

      

   

   

30,327

      

      

   

0

      

   

   

30,327

      

Total stockholders’ and member’s equity

   

527,880

      

      

   

527,146

      

   

   

906,705

      

   

   

392,954

      

      

   

(1,834,376

)

   

   

520,309

      

Total liabilities and stockholders’ and member’s equity

$

527,880

      

      

$

1,403,888

      

   

$

1,060,182

      

   

$

639,696

      

      

$

(2,479,798

)

   

$

1,151,848

      

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 25 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2012

(In thousands, except par value)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

ASSETS

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Current assets:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Cash and cash equivalents

$

0

      

      

$

0

      

   

$

80,903

      

   

$

142,263

      

      

$

0

      

   

$

223,166

      

Receivables, net of allowances of $401

   

0

      

      

   

426

      

   

   

44,728

      

   

   

79,481

      

      

   

0

      

   

   

124,635

      

Inventories of products

   

0

      

      

   

0

      

   

   

180,776

      

   

   

159,547

      

      

   

0

      

   

   

340,323

      

Inventories of materials and supplies

   

0

      

      

   

0

      

   

   

8,013

      

   

   

2,318

      

      

   

0

      

   

   

10,331

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

5,768

      

   

   

2,101

      

      

   

0

      

   

   

7,869

      

Other current assets

   

0

      

      

   

3,787

      

   

   

691

      

   

   

23,885

      

      

   

0

      

   

   

28,363

      

Total current assets

   

0

      

      

   

4,213

      

   

   

320,879

      

   

   

409,595

      

      

   

0

      

   

   

734,687

      

Property, plant and equipment, less accumulated depreciation of $311,779

   

0

      

      

   

56,626

      

   

   

222,956

      

   

   

101,623

      

      

   

0

      

   

   

381,205

      

Intangible assets, less accumulated amortization of $68,531

   

0

      

      

   

41,056

      

   

   

22,337

      

   

   

0

      

      

   

0

      

   

   

63,393

      

Investment in consolidated subsidiaries

   

526,725

      

      

   

1,258,814

      

   

   

0

      

   

   

0

      

      

   

(1,785,539

)

   

   

0

      

Investment in unconsolidated joint venture

   

0

      

      

   

813

      

   

   

0

      

   

   

12,769

      

      

   

0

      

   

   

13,582

      

Debt issuance costs

   

0

      

      

   

10,846

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

10,846

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

0

      

   

   

79

      

      

   

0

      

   

   

79

      

Other long-term assets

   

0

      

      

   

1,500

      

   

   

480,756

      

   

   

193,141

      

      

   

(650,000

)

   

   

25,397

      

Total assets

$

526,725

      

      

$

1,373,868

      

   

$

1,046,928

      

   

$

717,207

      

      

$

(2,435,539

)

   

$

1,229,189

      

LIABILITIES AND STOCKHOLDERS’ AND MEMBER’S EQUITY

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Current liabilities:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Current portion of long-term debt

$

0

      

      

$

15,074

      

   

$

0

      

   

$

0

      

      

$

0

      

   

$

15,074

      

Accounts payable-trade

   

0

      

      

   

2,072

      

   

   

44,304

      

   

   

52,791

      

      

   

0

      

   

   

99,167

      

Other payables and accruals

   

0

      

      

   

8,995

      

   

   

21,744

      

   

   

20,239

      

      

   

0

      

   

   

50,978

      

Due to related party

   

0

      

      

   

0

      

   

   

0

      

   

   

16,080

      

      

   

0

      

   

   

16,080

      

Deferred income taxes

   

0

      

      

   

0

      

   

   

0

      

   

   

513

      

      

   

0

      

   

   

513

      

Total current liabilities

   

0

      

      

   

26,141

      

   

   

66,048

      

   

   

89,623

      

      

   

0

      

   

   

181,812

      

Long-term debt, net of current portion

   

0

      

      

   

432,943

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

432,943

      

Deferred income taxes

   

0

      

      

   

12,206

      

   

   

5,768

      

   

   

4,299

      

      

   

0

      

   

   

22,273

      

Other long-term liabilities

   

0

      

      

   

377,032

      

   

   

89,825

      

   

   

283,089

      

      

   

(650,000

)

   

   

99,946

      

Total liabilities

   

0

      

      

   

848,322

      

   

   

161,641

      

   

   

377,011

      

      

   

(650,000

)

   

   

736,974

      

Commitments and contingencies (note 10)

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Stockholders’ and member’s equity:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Preferred stock, $0.01 par value; 100,000 shares authorized; none issued

   

0

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

0

      

Common stock, $0.01 par value; 500,000 shares authorized; 32,277 shares issued and outstanding

   

323

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

323

      

Additional paid in capital

   

354,957

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

354,957

      

Member’s equity

   

0

      

      

   

526,725

      

   

   

938,374

      

   

   

320,440

      

      

   

(1,785,539

)

   

   

0

      

Retained earnings

   

171,445

      

      

   

0

      

   

   

0

      

   

   

0

      

      

   

0

      

   

   

171,445

      

Accumulated other comprehensive income (loss)

   

0

      

      

   

(1,179

)

   

   

(53,087

)

   

   

19,756

      

      

   

0

      

   

   

(34,510

)

Total stockholders’ and member’s equity

   

526,725

      

      

   

525,546

      

   

   

885,287

      

   

   

340,196

      

      

   

(1,785,539

)

   

   

492,215

      

Total liabilities and stockholders’ and member’s equity

$

526,725

      

      

$

1,373,868

      

   

$

1,046,928

      

   

$

717,207

      

      

$

(2,435,539

)

   

$

1,229,189

      

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 26 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended September 30, 2013

(Unaudited)

(In thousands)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

Sales revenue

$

0

      

      

$

0

      

   

$

156,550

      

   

$

210,570

      

      

$

(40,011

   

$

327,109

      

Cost of goods sold

   

0

      

      

   

(244

   

   

134,863

      

   

   

185,051

      

      

   

(40,011

   

   

279,659

      

Gross profit

   

0

      

      

   

244

   

   

   

21,687

      

   

   

25,519

      

      

   

0

      

   

   

47,450

      

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Research and development

   

0

      

      

   

0

      

   

   

4,307

      

   

   

3,106

      

      

   

0

      

   

   

7,413

      

Selling, general and administrative

   

0

      

      

   

6

      

   

   

15,268

      

   

   

7,156

      

      

   

0

      

   

   

22,430

      

Depreciation and amortization

   

0

      

      

   

4,080

      

   

   

7,902

      

   

   

3,832

      

      

   

0

      

   

   

15,814

      

Total operating expenses

   

0

      

      

   

4,086

      

   

   

27,477

      

   

   

14,094

      

      

   

0

      

   

   

45,657

      

Earnings (loss) in consolidated subsidiaries

   

(5,852

      

   

6,621

      

   

   

0

      

   

   

0

      

      

   

(769

   

   

0

      

Earnings of unconsolidated joint venture

   

0

      

      

   

0

      

   

   

0

      

   

   

117

      

      

   

0

      

   

   

117

      

Interest expense (income), net

   

0

      

      

   

9,381

      

   

   

(3,766

   

   

126

      

      

   

0

      

   

   

5,741

      

Income (loss) before income taxes

   

(5,852

      

   

(6,602

   

   

(2,024

   

   

11,416

      

      

   

(769

   

   

(3,831

Income tax expense (benefit)

   

0

      

      

   

(750

   

   

11

      

   

   

2,760

      

      

   

0

      

   

   

2,021

      

Consolidated net income (loss)

   

(5,852

      

   

(5,852

   

   

(2,035

   

   

8,656

      

      

   

(769

   

   

(5,852

Net loss attributable to noncontrolling interest

   

0

      

      

   

0

      

   

   

0

      

   

   

(254

      

   

0

      

   

   

(254

Net income (loss) attributable to Kraton

$

(5,852

      

$

(5,852

   

$

(2,035

   

$

8,910

      

      

$

(769

   

$

(5,598

   

 

   

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

   

 

 27 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Three months ended September 30, 2012

(Unaudited)

(In thousands)

   

 

   

Kraton

   

   

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

Sales revenue

$

0

      

   

$

0

      

   

$

163,070

      

   

$

218,801

      

      

$

(39,236

   

$

342,635

      

Cost of goods sold

   

0

      

   

   

(210

   

   

147,891

      

   

   

191,437

      

      

   

(39,326

   

   

299,882

      

Gross profit

   

0

      

   

   

210

      

   

   

15,179

      

   

   

27,364

      

      

   

0

      

   

   

42,753

      

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Research and development

   

0

      

   

   

0

      

   

   

4,770

      

   

   

2,631

      

      

   

0

      

   

   

7,401

      

Selling, general and administrative

   

0

      

   

   

11

      

   

   

16,151

      

   

   

7,285

      

      

   

0

      

   

   

23,447

      

Depreciation and amortization

   

0

      

   

   

4,079

      

   

   

8,715

      

   

   

3,315

      

      

   

0

      

   

   

16,109

      

Impairment of long-lived assets

   

0

      

   

   

0

      

   

   

5,434

      

   

   

0

      

      

   

0

      

   

   

5,434

      

Total operating expenses

   

0

      

   

   

4,090

      

   

   

35,070

      

   

   

13,231

      

      

   

0

      

   

   

52,391

      

Loss in consolidated subsidiaries

   

(15,499

   

   

(3,041

   

   

0

      

   

   

0

      

      

   

18,540

      

   

   

0

      

Earnings of unconsolidated joint venture

   

0

      

   

   

0

      

   

   

0

      

   

   

133

      

      

   

0

      

   

   

133

      

Interest expense (income), net

   

0

      

   

   

9,696

      

   

   

(3,632

   

   

1,570

      

      

   

0

      

   

   

7,634

      

Income (loss) before income taxes

   

(15,499

   

   

(16,617

   

   

(16,259

   

   

12,696

      

      

   

18,540

      

   

   

(17,139

Income tax expense (benefit)

   

0

      

   

   

(1,118

   

   

(661

   

   

139

      

      

   

0

      

   

   

(1,640

Net income (loss)

$

(15,499

   

$

(15,499

   

$

(15,598

   

$

12,557

      

      

$

18,540

      

   

$

(15,499

   

 

   

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 28 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Nine months ended September 30, 2013

(Unaudited)

(In thousands)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

Sales revenue

$

0

      

      

$

0

      

   

$

498,775

      

   

$

624,015

      

      

$

(121,031

   

$

1,001,759

      

Cost of goods sold

   

0

      

      

   

1,720

      

   

   

407,224

      

   

   

546,624

      

      

   

(121,031

   

   

834,537

      

Gross profit (loss)

   

0

      

      

   

(1,720

   

   

91,551

      

   

   

77,391

      

      

   

0

      

   

   

167,222

      

Operating expenses:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Research and development

   

0

      

      

   

0

      

   

   

13,087

      

   

   

10,685

      

      

   

0

      

   

   

23,772

      

Selling, general and administrative

   

0

      

      

   

154

      

   

   

50,840

      

   

   

22,554

      

      

   

0

      

   

   

73,548

      

Depreciation and amortization

   

0

      

      

   

12,239

      

   

   

23,521

      

   

   

10,893

      

      

   

0

      

   

   

46,653

      

Total operating expenses

   

0

      

      

   

12,393

      

   

   

87,448

      

   

   

44,132

      

      

   

0

      

   

   

143,973

      

Earnings (loss) in consolidated subsidiaries

   

(5,699

      

   

41,165

      

   

   

0

      

   

   

0

      

      

   

(35,466

   

   

0

      

Earnings of unconsolidated joint venture

   

0

      

      

   

0

      

   

   

0

      

   

   

372

      

      

   

0

      

   

   

372

      

Interest expense (income), net

   

0

      

      

   

34,315

      

   

   

(10,886

   

   

1,519

      

      

   

0

      

   

   

24,948

      

Income (loss) before income taxes

   

(5,699

      

   

(7,263

   

   

14,989

      

   

   

32,112

      

      

   

(35,466

   

   

(1,327

Income tax expense (benefit)

   

0

      

      

   

(1,564

   

   

32

      

   

   

5,904

      

      

   

0

      

   

   

4,372

      

Consolidated net income (loss)

   

(5,699

      

   

(5,699

   

   

14,957

      

   

   

26,208

      

      

   

(35,466

   

   

(5,699

Net loss attributable to noncontrolling interest

   

0

      

      

   

0

      

   

   

0

      

   

   

(182

      

   

0

      

   

   

(182

Net income (loss) attributable to Kraton

$

(5,699

      

$

(5,699

   

$

14,957

      

   

$

26,390

      

      

$

(35,466

   

$

(5,517

   

 

   

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 29 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

Nine months ended September 30, 2012

(Unaudited)

(In thousands)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

   

Consolidated

   

Sales revenue

$

0

      

      

$

0

      

   

$

558,547

      

   

$

685,969

      

      

$

(117,812

   

$

1,126,704

      

Cost of goods sold

   

0

      

      

   

(1,295

   

   

473,510

      

   

   

580,549

      

      

   

(117,812

   

   

934,952

      

Gross profit

   

0

      

      

   

1,295

      

   

   

85,037

      

   

   

105,420

      

      

   

0

      

   

   

191,752

      

Operating expenses:

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

Research and development

   

0

      

      

   

0

      

   

   

14,483

      

   

   

8,474

      

      

   

0

      

   

   

22,957

      

Selling, general and administrative

   

0

      

      

   

11

      

   

   

52,124

      

   

   

24,088

      

      

   

0

      

   

   

76,223

      

Depreciation and amortization

   

0

      

      

   

12,238

      

   

   

25,874

      

   

   

9,731

      

      

   

0

      

   

   

47,843

      

Impairment of long-lived assets

   

0

      

      

   

0

      

   

   

5,434

      

   

   

0

      

      

   

0

      

   

   

5,434

      

Total operating expenses

   

0

      

      

   

12,249

      

   

   

97,915

      

   

   

42,293

      

      

   

0

      

   

   

152,457

      

Earnings in consolidated subsidiaries

   

13,261

      

      

   

51,692

      

   

   

0

      

   

   

0

      

      

   

(64,953

   

   

0

      

Earnings of unconsolidated joint venture

   

0

      

      

   

0

      

   

   

0

      

   

   

433

      

      

   

0

      

   

   

433

      

Interest expense (income), net

   

0

      

      

   

29,028

      

   

   

(11,145

   

   

4,223

      

      

   

0

      

   

   

22,106

      

Income (loss) before income taxes

   

13,261

      

      

   

11,710

      

   

   

(1,733

   

   

59,337

      

      

   

(64,953

   

   

17,622

      

Income tax expense (benefit)

   

0

      

      

   

(1,551

   

   

(1,778

   

   

7,690

      

      

   

0

      

   

   

4,361

      

Net income

$

13,261

      

      

$

13,261

      

   

$

45

      

   

$

51,647

      

      

$

(64,953

   

$

13,261

      

   

 

   

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 30 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three months ended September 30, 2013

(Unaudited)

(In thousands)

   

 

   

Kraton

   

   

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

   

Eliminations

   

   

Consolidated

   

Net income (loss) attributable to Kraton

$

(5,852

      

$

(5,852

      

$

(2,035

      

$

8,910

      

   

$

(769

   

$

(5,598

Other comprehensive income (loss):

   

         

   

      

   

   

   

      

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

Foreign currency translation adjustments, net of tax of $0

   

0

      

      

   

(201

      

   

0

      

      

   

9,712

   

   

   

0

      

   

   

9,511

   

Unrealized gain (loss) of net investment hedge, net of tax of $0

   

0

      

      

   

36

      

      

   

0

      

      

   

(301

)

   

   

0

      

   

   

(265

)

Other comprehensive income (loss), net of tax

   

0

      

      

   

(165

      

   

0

      

      

   

9,411

   

   

   

0

      

   

   

9,246

   

Comprehensive income (loss) attributable to Kraton

   

(5,852

      

   

(6,017

      

   

(2,035

      

   

18,321

   

   

   

(769

   

   

3,648

   

Comprehensive income attributable to noncontrolling interest

   

0

      

      

   

0

      

      

   

0

      

      

   

178

   

   

   

0

      

   

   

178

   

Consolidated comprehensive income (loss)

$

(5,852

      

$

(6,017

      

$

(2,035

      

$

18,499

   

   

$

(769

   

$

3,826

   

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 31 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Three months ended September 30, 2012

(Unaudited)

(In thousands)

   

 

   

Kraton

   

   

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

      

Eliminations

   

      

Consolidated

   

Net income (loss) attributable to Kraton

$

(15,499

   

$

(15,499

   

$

(15,598

   

$

12,557

      

      

$

18,540

      

      

$

(15,499

Other comprehensive income (loss):

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

      

   

   

   

      

   

   

   

Foreign currency translation adjustments, net of tax of $0

   

0

      

   

   

(122

   

   

1

      

   

   

7,141

      

      

   

0

      

      

   

7,020

      

Unrealized loss on interest rate swaps, net of tax of $0

   

0

      

   

   

(9

   

   

0

      

   

   

0

      

      

   

0

      

      

   

(9

Unrealized loss of net investment hedge, net of tax of $0

   

0

      

   

   

(1,155

   

   

0

      

   

   

0

      

      

   

0

      

      

   

(1,155

Other comprehensive income (loss), net of tax

   

0

      

   

   

(1,286

   

   

1

      

   

   

7,141

      

      

   

0

      

      

   

5,856

      

Consolidated comprehensive income (loss)

$

(15,499

   

$

(16,785

   

$

(15,597

   

$

19,698

      

      

$

18,540

      

      

$

(9,643

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 32 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)

Nine months ended September 30, 2013

(Unaudited)

(In thousands)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

      

Non-Guarantor
Subsidiaries

   

   

Eliminations

   

   

Consolidated

   

Net income (loss) attributable to Kraton

$

(5,699

      

$

(5,699

   

$

14,957

      

      

$

26,390

      

   

$

(35,466

   

$

(5,517

Other comprehensive income (loss):

   

   

   

      

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

Foreign currency translation adjustments, net of tax of $0

   

0

      

      

   

(203

   

   

0

      

      

   

(3,532

   

   

0

      

   

   

(3,735

Unrealized gain on interest rate swaps, net of tax of $0

   

0

      

      

   

837

      

   

   

0

      

      

   

0

      

   

   

0

      

   

   

837

      

Unrealized loss of net investment hedge, net of tax of $0

   

0

      

      

   

(189

   

   

0

      

      

   

(301

   

   

0

      

   

   

(490

)

Other comprehensive income (loss), net of tax

   

0

      

      

   

445

      

   

   

0

      

      

   

(3,833

   

   

0

      

   

   

(3,388

Comprehensive income (loss) attributable to Kraton

   

(5,699

      

   

(5,254

   

   

14,957

      

      

   

22,557

      

   

   

(35,466

   

   

(8,905

Comprehensive income attributable to noncontrolling interest

   

0

      

      

   

0

      

   

   

0

      

      

   

111

   

   

   

0

      

   

   

111

   

Consolidated comprehensive income (loss)

$

(5,699

      

$

(5,254

   

$

14,957

      

      

$

22,668

      

   

$

(35,466

   

$

(8,794

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 33 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

Nine months ended September 30, 2012

(Unaudited)

(In thousands)

   

 

   

Kraton

   

      

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

      

Non-Guarantor
Subsidiaries

   

   

Eliminations

   

   

Consolidated

   

Net income attributable to Kraton

$

13,261

      

      

$

13,261

      

   

$

45

      

      

$

51,647

      

   

$

(64,953

   

$

13,261

      

Other comprehensive income (loss):

   

   

   

      

   

   

   

   

   

   

   

      

   

   

   

   

   

   

   

   

   

   

   

Foreign currency translation adjustments, net of tax of $0

   

0

      

      

   

(190

   

   

0

      

      

   

(5,835

   

   

0

      

   

   

(6,025

Unrealized loss on interest rate swaps, net of tax of $0

   

0

      

      

   

(143

   

   

0

      

      

   

0

      

   

   

0

      

   

   

(143

Unrealized gain of net investment hedge, net of tax of $0

   

0

      

      

   

648

      

   

   

0

      

      

   

0

      

   

   

0

      

   

   

648

      

Other comprehensive income (loss), net of tax

   

0

      

      

   

315

      

   

   

0

      

      

   

(5,835

   

   

0

      

   

   

(5,520

Consolidated comprehensive income

$

13,261

      

      

$

13,576

      

   

$

45

      

      

$

45,812

      

   

$

(64,953

   

$

7,741

      

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 34 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Nine months ended September 30, 2013

(Unaudited)

(In thousands)

   

 

   

Kraton

   

   

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

   

Eliminations

   

   

Consolidated

   

Cash flows provided by (used in) operating activities

$

0

      

   

$

14,859

      

   

$

(65,805

   

$

109,033

      

   

$

0

      

   

$

58,087

   

Cash flows provided by (used in) investing activities:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Repayments of intercompany loans

   

0

      

   

   

68,962

      

   

   

0

      

   

   

0

      

   

   

(68,962

   

   

0

      

Purchase of property, plant and equipment

   

0

      

   

   

0

      

   

   

(26,414

   

   

(31,508

   

   

0

      

   

   

(57,922

Purchase of software and other intangibles

   

0

      

   

   

0

      

   

   

(2,861

   

   

(245

   

   

0

      

   

   

(3,106

Settlement of net investment hedge

   

0

      

   

   

(2,490

   

   

0

      

   

   

0

      

   

   

0

      

   

   

(2,490

Net cash provided by (used in) investing activities

   

0

      

   

   

66,472

      

   

   

(29,275

   

   

(31,753

   

   

(68,962

   

   

(63,518

Cash flows provided by (used in) financing activities:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Proceeds from debt

   

0

      

   

   

0

      

   

   

40,000

      

   

   

0

      

   

   

0

      

   

   

40,000

      

Repayments of debt

   

0

      

   

   

(96,875

   

   

(40,000

   

   

0

      

   

   

0

      

   

   

(136,875

Capital lease payments

   

0

      

   

   

0

      

   

   

(950

   

   

0

      

   

   

0

      

   

   

(950

Cash contributions from member

   

0

      

   

   

15,544

      

   

   

0

      

   

   

(15,544

   

   

0

      

   

   

0

      

Cash distributions to member

   

(310

   

   

0

      

   

   

0

      

   

   

310

      

   

   

0

      

   

   

0

      

Contribution from noncontrolling interest

   

0

      

   

   

0

      

   

   

0

      

   

   

30,216

      

   

   

0

      

   

   

30,216

      

Proceeds from the exercise of stock options

   

310

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

310

      

Debt issuance costs

   

0

      

   

   

0

      

   

   

(3,310

   

   

(1,484

   

   

0

      

   

   

(4,794

Proceeds from (repayments of) intercompany loans

   

0

      

   

   

0

      

   

   

28,891

      

   

   

(97,853

   

   

68,962

      

   

   

0

      

Net cash provided by (used in) financing activities

   

0

      

   

   

(81,331

   

   

24,631

      

   

   

(84,355

   

   

68,962

      

   

   

(72,093

Effect of exchange rate differences on cash

   

0

      

   

   

0

      

   

   

0

      

   

   

(1,012

   

   

0

      

   

   

(1,012

Net decrease in cash and cash equivalents

   

0

      

   

   

0

      

   

   

(70,449

   

   

(8,087

   

   

0

      

   

   

(78,536

Cash and cash equivalents, beginning of period

   

0

      

   

   

0

      

   

   

80,903

      

   

   

142,263

      

   

   

0

      

   

   

223,166

      

Cash and cash equivalents, end of period

$

0

      

   

$

0

      

   

$

10,454

      

   

$

134,176

      

   

$

0

      

   

$

144,630

      

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

   

 

 35 


   

KRATON PERFORMANCE POLYMERS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

Nine months ended September 30, 2012

(Unaudited)

(In thousands)

   

 

   

Kraton

   

   

Kraton
Polymers
LLC (1)

   

   

Guarantor
Subsidiaries

   

   

Non-Guarantor
Subsidiaries

   

   

Eliminations

   

   

Consolidated

   

Cash flows provided by (used in) operating activities

$

0

      

   

$

(69,068

   

$

136,814

      

   

$

34,442

      

   

$

0

      

   

$

102,188

      

Cash flows provided by (used in) investing activities:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Repayments of intercompany loans

   

0

      

   

   

14,132

      

   

   

0

      

   

   

0

      

   

   

(14,132

   

   

0

      

Purchase of property, plant and equipment

   

0

      

   

   

0

      

   

   

(33,094

   

   

(9,342

   

   

0

      

   

   

(42,436

Purchase of software and other intangibles

   

0

      

   

   

0

      

   

   

(1,842

   

   

53

      

   

   

0

      

   

   

(1,789

Settlement of net investment hedge

   

0

      

   

   

1,648

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

1,648

      

Net cash provided by (used in) investing activities

   

0

      

   

   

15,780

      

   

   

(34,936

   

   

(9,289

   

   

(14,132

   

   

(42,577

Cash flows provided by (used in) financing activities:

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

   

Proceeds from debt

   

0

      

   

   

101,250

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

101,250

      

Repayments of debt

   

0

      

   

   

(45,626

   

   

0

      

   

   

0

      

   

   

0

      

   

   

(45,626

Cash contributions from member

   

0

      

   

   

820

      

   

   

0

      

   

   

0

      

   

   

(820

   

   

0

      

Cash distributions to member

   

(820

   

   

0

      

   

   

0

      

   

   

0

      

   

   

820

      

   

   

0

      

Proceeds from the exercise of stock options

   

820

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

0

      

   

   

820

      

Debt issuance costs

   

0

      

   

   

(3,156

   

   

0

      

   

   

0

      

   

   

0

      

   

   

(3,156

Proceeds from (repayments of) intercompany loans

   

0

      

   

   

0

      

   

   

(33,722

   

   

19,590

      

   

   

14,132

      

   

   

0

      

Net cash provided by (used in) financing activities

   

0

      

   

   

53,288

      

   

   

(33,722

   

   

19,590

      

   

   

14,132

      

   

   

53,288

      

Effect of exchange rate differences on cash

   

0

      

   

   

0

      

   

   

0

      

   

   

793

      

   

   

0

      

   

   

793

      

Net increase in cash and cash equivalents

   

0

      

   

   

0

      

   

   

68,156

      

   

   

45,536

      

   

   

0

      

   

   

113,692

      

Cash and cash equivalents, beginning of period

   

0

      

   

   

0

      

   

   

6,030

      

   

   

82,549

      

   

   

0

      

   

   

88,579

      

Cash and cash equivalents, end of period

$

0

      

   

$

0

      

   

$

74,186

      

   

$

128,085

      

   

$

0

      

   

$

202,271

      

   

 

   

 

(1)

Kraton Polymers LLC and Kraton Polymers Capital Corporation, a financing subsidiary, collectively, the Issuers, are co-issuers of the 6.75% senior notes due March 1, 2019. Kraton Polymers Capital Corporation has minimal assets and income. We do not believe that separate financial information concerning the Issuers would provide additional information that would be material to investors in making an investment decision.

   

16. Subsequent Events

We have evaluated significant events and transactions that occurred after the balance sheet date and determined that there were no events or transactions other than those disclosed above that would require recognition or disclosure in our condensed consolidated financial statements for the period ended September 30, 2013.

   

   

 

 36 


   

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

INTRODUCTION

You should read the following discussion of our financial condition and results of operations with our audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K as of and for the year ended December 31, 2012. This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to, the risk factors discussed in the “Risk Factors” section of our most recent Form 10-K, as well as in “Factors Affecting Our Results of Operations” and elsewhere in this Form 10-Q. Actual results may differ materially from those contained in any forward-looking statements.

OVERVIEW

We are a leading global producer of styrenic block copolymers (“SBCs”) and other engineered polymers. We market our products under the Kraton®, CariflexTM and NEXARTM brands. SBCs are highly-engineered synthetic elastomers, which we invented and commercialized almost 50 years ago, that enhance the performance of numerous end use products by imparting greater flexibility, resilience, strength, durability and processability.

Our polymers are typically formulated or compounded with other products to achieve improved, customer-specific performance characteristics in a variety of applications. We seek to maximize the value of our product portfolio by emphasizing complex or specialized polymers and innovations that yield higher margins. We sometimes refer to these complex or specialized polymers or innovations as being more “differentiated.”

Our products are found in many everyday applications, including personal care products such as disposable diapers and the rubberized grips of toothbrushes, razor blades and power tools. Our products are also used to impart tack and shear properties in a wide variety of adhesive products and to impart characteristics such as, flexibility and durability in sealants and corrosion resistance in coatings. Our paving and roofing applications provide durability, extending road and roof life.

We also produce Cariflex isoprene rubber and isoprene rubber latex. Our Cariflex products are highly-engineered, non-SBC synthetic substitutes for natural rubber and natural rubber latex. Our Cariflex products, which have not been found to contain the proteins present in natural rubber latex and are, therefore, not known to cause allergies, are used in applications such as surgical gloves and condoms. We believe the versatility of Cariflex provides opportunities for new, high margin applications.

We have a portfolio of innovations at various stages of development and commercialization, including

 

·

polyvinyl chloride alternatives for wire and cable, and medical applications;

 

·

polymers and compounds for soft skin and coated fabric applications for transportation and consumer markets;

 

·

our NEXAR family of membrane polymers for water filtration and breathable fabrics; and

 

·

synthetic cement formulations and other oilfield applications.

Our products are manufactured along the following primary product lines based upon polymer chemistry and process technologies:

 

·

un-hydrogenated SBCs (“USBCs”);

 

·

hydrogenated SBCs (“HSBCs”);

 

·

Cariflex isoprene rubber (“IR”) and isoprene rubber latex (“IRL”); and

 

·

compounds.

 

 37 


   

The majority of worldwide SBC production is dedicated to USBCs, which are primarily used in paving and roofing, in adhesives, sealants and coatings and in footwear applications. HSBCs, which are significantly more complex and capital-intensive to manufacture than USBCs, are primarily used in more differentiated applications, such as soft-touch and flexible materials, personal hygiene products, medical products, automotive components and certain adhesives and sealant applications.

   

 

   

      

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

Product Line Sales Revenue:

      

2013

   

   

2012

   

   

2013

   

   

2012

   

USBCs

      

   

58.9

   

   

60.7

   

   

58.1

   

   

59.5

HSBCs

      

   

30.2

   

   

30.2

   

   

31.1

   

   

31.4

Cariflex

      

   

8.6

   

   

7.1

   

   

8.4

   

   

6.8

Compounds

      

   

2.2

   

   

1.9

   

   

2.3

   

   

2.1

Other

      

   

0.1

   

   

0.1

   

   

0.1

   

   

0.2

   

 

   

      

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

End Use Markets

      

2013

   

   

2012

   

   

2013

   

   

2012

   

Advanced Materials

      

   

24.8

   

   

27.3

   

   

26.8

   

   

26.8

Adhesives, Sealants and Coatings

      

   

36.0

   

   

34.0

   

   

37.5

   

   

35.6

Paving and Roofing

      

   

30.5

   

   

31.5

   

   

27.2

   

   

30.6

Cariflex

      

   

8.6

   

   

7.1

   

   

8.4

   

   

6.8

Other

      

   

0.1

   

   

0.1

   

   

0.1

   

   

0.2

2013 Third Quarter Financial Overview

 

·

Sales volume was 83.5 kilotons in the third quarter of 2013, an increase of 5.3% compared to 79.3 kilotons in the third quarter of 2012.

 

·

Sales revenue was $327.1 million in the third quarter of 2013 compared to $342.6 million in the third quarter 2012.

 

·

Gross profit was $47.5 million in the third quarter of 2013 compared to $42.8 million in the third quarter of 2012. Gross profit at estimated current replacement cost (“ECRC”) was $68.1 million in the third quarter of 2013 compared to $80.4 million in the third quarter of 2012. Included in gross profit and gross profit at ECRC in the third quarter of 2013 were turnaround and related costs aggregating $6.1 million. These costs consisted of $3.5 million associated with activities related to MACT legislation and $2.6 million of costs related to scheduled turnaround activity. On a comparable basis, scheduled turnaround activities in the third quarter of 2012 amounted to $1.2 million.

 

·

Adjusted EBITDA was $24.1 million in the third quarter of 2013 compared to $13.2 million in the third quarter 2012. Adjusted EBITDA at ECRC was $44.8 million in the third quarter of 2013 compared to $50.8 million in the third quarter 2012.

 

·

Net loss attributable to Kraton was $(5.6) million or $(0.17) per diluted share, compared to net loss of $(15.5) million or $(0.48) per diluted share in the third quarter 2012. Diluted earnings per share were impacted by items that are discussed further in Net loss attributable to Kraton.

 

·

Cash provided by operating activities was $62.5 million in the third quarter of 2013 compared to $33.5 million in the third quarter of 2012.

 

 38 


   

RESULTS OF OPERATIONS

Factors Affecting Our Results of Operations

Raw Materials and Product Mix. Our results of operations are directly affected by the cost of raw materials. We use butadiene, styrene and isoprene as our primary raw materials in manufacturing our products. On a FIFO basis, these monomers together represented approximately $158.4 million and $191.8 million or 56.6% and 64.0% of our total cost of goods sold for the three months ended September 30, 2013 and 2012, respectively, and $477.4 million and $585.7 million or 57.2% and 62.6% of our total cost of goods sold for the nine months ended September 30, 2013 and 2012, respectively. Since the cost of our three primary raw materials comprise a significant amount of our total cost of goods sold, our selling prices for our products and therefore our total sales revenue are impacted by movements in our raw material costs, as well as the cost of other inputs. In addition, product mix can have an impact on our overall unit selling prices because we provide an extensive product offering and therefore experience a wide range of unit selling prices.

The cost of these monomers has generally correlated with changes in energy prices, supply and demand factors, and prices for natural and synthetic rubber. In aggregate, average purchase prices for these monomers decreased during the three months ended September 30, 2013 compared to the three months ended June 30, 2013. Average purchase prices decreased for butadiene and isoprene during the three months ended September 30, 2013 compared to the same periods in 2012, with an increase in average purchase prices for styrene. Average purchase prices decreased for butadiene and isoprene during the nine months ended September 30, 2013 compared to the same periods in 2012, with an increase in average purchase prices for styrene.

We use the FIFO basis of accounting for inventory and cost of goods sold and therefore gross profit. In periods of raw material price volatility, reported results under FIFO will differ from what the results would have been if cost of goods sold were based on ECRC. Specifically, in periods of rising raw material costs, reported gross profit will be higher under FIFO than under ECRC. Conversely, in periods of declining raw material costs, reported gross profit will be lower under FIFO than under ECRC. In recognition of the fact that the cost of raw materials affects our results of operations and the comparability of our results of operations we provide the spread between FIFO and ECRC.

 

·

In the three and nine months ended September 30, 2013, reported results under FIFO were lower than results would have been on an ECRC basis by $20.7 million and $23.5 million, respectively; and

 

·

In the three and nine months ended September 30, 2012, reported results under FIFO were lower than results would have been on an ECRC basis by $37.6 million and $20.3 million, respectively.

 

·

We currently anticipate that our results will reflect a negative spread between FIFO and ECRC of approximately $8.0 million in the fourth quarter of 2013. This expectation is based on numerous complex and interrelated assumptions with respect to monomer costs and ending inventory levels in the fourth quarter and the actual results may be significantly different based on fourth quarter results.

International Operations and Currency Fluctuations. We operate a geographically diverse business, serving customers in over 60 countries from five manufacturing facilities on four continents. Although we sell and manufacture our products in many countries, our sales and production costs are mainly denominated in U.S. dollars, Euro, Japanese Yen and Brazilian Reais. From time to time, we use hedging strategies to reduce our exposure to currency fluctuations.

We generated our sales revenue from customers located in the following regions.

   

 

   

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

Revenue by Geography:

   

2013

   

   

2012

   

   

2013

   

   

2012

   

Americas

   

   

38.9

%

   

   

36.9

%

   

   

39.8

%

   

   

40.3

%

Europe, Middle East and Africa

   

   

41.0

%

   

   

41.5

%

   

   

39.2

%

   

   

39.9

%

Asia Pacific

   

   

20.1

%

   

   

21.6

%

   

   

21.0

%

   

   

19.8

%

 

 39 


   

Our financial results are subject to gains and losses on currency translations, which occur when the financial statements of our foreign operations are translated into U.S. dollars. The financial statements of operations outside the United States where the local currency is considered to be the functional currency are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and the average exchange rate for each period for revenues, expenses, gains and losses and cash flows. The effect of translating the balance sheet into U.S. dollars is included as a component of accumulated other comprehensive income (loss). Any appreciation of the functional currencies against the U.S. dollar will increase the U.S. dollar equivalent of amounts of revenues, expenses, gains and losses and cash flows, and any depreciation of the functional currencies will decrease the U.S. dollar amounts reported. Our results of operations are also subject to currency transaction risk. We incur currency transaction risk when we enter into either a purchase or sale transaction using a currency other than the local currency of the transacting entity. The estimated impact from currency fluctuations amounted to pre-tax losses of $3.1 million and $2.1 million for the three months ended September 30, 2013 and 2012, respectively, and pre-tax losses of $5.0 million and $4.9 million for the nine months ended September 30, 2013 and 2012, respectively. The primary driver for the increase in our pre-tax losses for the periods presented was the change in foreign currency exchange rates between the Japanese Yen and U.S. dollar.

Seasonality. Seasonal changes and weather conditions typically affect the Paving and Roofing end use market generally resulting in higher sales volumes into this end use market in the second and third quarters of the calendar year versus the first and fourth quarters of the calendar year.

Three Months Ended September 30, 2013 Compared to Three Months Ended September 30, 2012

Sales Revenue

Sales revenue amounted to $327.1 million for the three months ended September 30, 2013 compared to $342.6 million for the three months ended September 30, 2012. The $15.5 million or 4.5% revenue decline (a decline of $16.1 million or 4.7% excluding a $0.6 million effect of currency fluctuations), included a $15.7 million increase from a 5.3% increase in sales volume from 79.3 kilotons in the third quarter of 2012 to 83.5 kilotons in the third quarter of 2013. The sales volume growth was in the Americas and Europe. More than offsetting the increase in revenue resulting from higher sales volume was a decline of $31.9 million due to a reduction in global product sales prices associated with lower average raw material costs.

With respect to sales revenue in each of our end use markets:

 

·

Advanced Materials. Sales revenue amounted to $81.2 million for the three months ended September 30, 2013 compared to $93.7 million for the three months ended September 30, 2012. The $12.5 million or 13.3% revenue decline (a decline of $12.6 million or 13.5% excluding a $0.2 million effect of currency fluctuations) was largely driven by a 7.3% decline in sales volumes primarily attributable to base personal care and less differentiated applications, and to a lesser extent, lower average selling prices, reflecting lower average cost of raw materials, primarily butadiene. With respect to innovation sales volumes, we experienced growth in personal care and consumer applications, partially offset by lower sales volumes into wire and cable and medical applications.

 

·

Adhesives, Sealants and Coatings. Sales revenue amounted to $117.6 million for the three months ended September 30, 2013 compared to $116.5 million for the three months ended September 30, 2012. The $1.1 million or 0.9% revenue increase (an increase of $1.8 million or 1.5% excluding a $0.7 million effect of currency fluctuations) was attributable to a 7.4% increase in sales volumes, primarily due to the timing of sales into lubricant additive applications, partially offset by lower sales into cable gel applications. The increase in sales revenue attributable to increased sales volumes was nearly offset by the lower average selling prices, which reflect the lower average raw material costs, primarily butadiene and isoprene.

 

·

Paving and Roofing. Sales revenue amounted to $99.7 million for the three months ended September 30, 2013 compared to $108.1 million for the three months ended September 30, 2012. The $8.3 million or 7.7% revenue decline (a decline of $10.4 million or 9.6% excluding a $2.1 million effect of currency fluctuations) was attributable to lower average selling prices, which reflect the lower average cost of raw materials, primarily butadiene. The impact of lower average selling prices more than offset the 9.1% increase in sales volumes, primarily driven by higher volume for roofing products in Europe. Global paving sales volumes were essentially flat in the third quarter of 2013 compared to the third quarter of 2012.  Innovation sales volumes increased on higher sales of roofing innovation grades in North America and Europe.

 

 40 


   

   

 

·

CariflexTM. Sales revenue amounted to $28.2 million for the three months ended September 30, 2013 compared to $24.2 million for the three months ended September 30, 2012. The $4.0 million or 16.7% revenue increase (an increase of $5.0 million or 20.8% excluding a $1.0 million effect of currency fluctuations) was attributable to increased sales volumes in surgical glove and other medical applications, including innovation grades, partially offset by lower average selling prices.

Cost of Goods Sold

Cost of goods sold amounted to $279.7 million for the three months ended September 30, 2013 compared to $299.9 million for the three months ended September 30, 2012. The $20.2 million or 6.7% decrease was driven largely by a $42.3 million reduction in raw material costs, of which $17.0 million relates to the change in the spread between FIFO and ECRC.

Partially offsetting the decrease in cost of goods sold associated with lower raw material costs was the effect of higher sales volume, which resulted in an increase in cost of goods sold of $11.1 million. During the third quarter of 2013, we undertook turnaround activities conducted primarily at our Belpre, Ohio facility that included a non-recurring plant-wide utility outage in addition to the scheduled turnaround activity. The utility outage was a precursor to the previously disclosed, multi-year capital project associated with MACT legislation that entails replacement of our coal-burning boilers with natural gas boilers. The aggregate cost of the scheduled turnaround and the MACT related production downtime in the third quarter was $6.1 million, of which $3.5 million was attributable to the non-recurring MACT related production downtime and $2.6 million which was related to the scheduled turnarounds. Costs associated with scheduled turnaround activities in the third quarter of 2012 were $1.2 million. As a result, $4.9 million of the increase in cost of goods sold was associated with these turnaround costs.  In addition, currency fluctuations resulted in an increase in cost of goods sold of $3.2 million.

Gross Profit

Gross profit amounted to $47.5 million for the three months ended September 30, 2013 compared to $42.8 million for the three months ended September 30, 2012. The $4.7 million or 11.0% increase includes a period over period benefit of $17.0 million due to the spread between FIFO and ECRC.  Gross profit at ECRC was $68.1 million in the third quarter of 2013 compared to $80.4 million in the third quarter of 2012, a decrease of $12.3 million or 15.3%, largely due to the factors discussed in “Cost of Goods Sold.” Gross profit as a percentage of sales revenue was 14.5% and 12.5% for the three months ended September 30, 2013 and 2012, respectively.

Operating Expenses

 

·

Research and Development. Research and development expenses were $7.4 million in each of the third quarters of 2013 and 2012 and amounted to 2.3% and 2.2% of sales revenue for the three months ended September 30, 2013 and 2012, respectively.

 

·

Selling, General and Administrative. Selling, general and administrative expenses decreased $1.0 million or 4.3%. The decrease was primarily due to a $1.5 million decrease in employee related costs, $0.4 million in lower legal expenses, a $0.3 million decrease in information technology costs, partially offset by a $1.0 million increase in restructuring and other costs, and a $1.0 million increase in other professional fees. Selling, general and administrative expenses were 6.9% and 6.8% of sales revenue for the three months ended September 30, 2013 and 2012, respectively.

 

·

Depreciation and Amortization. Depreciation and amortization decreased $0.3 million or 1.8%, primarily due to the extended compliance deadline for our coal-burning boilers at our Belpre, Ohio, facility, pursuant to the revised MACT rule.

 

·

Impairment of long-lived assets. During the three months ended September 30, 2012, we recorded a pre-tax charge of $5.4 million in the aggregate for the impairment of long-lived assets, of which $3.4 million was related to the HSBC facility in Mailiao, Taiwan and $2.0 million related to other long-lived assets.

Interest expense, net

Interest expense, net decreased $1.9 million or 24.8% to $5.7 million for the three months ended September 30, 2013 from $7.6 million for the three months ended September 30, 2012. The decrease was primarily due to a lower average debt balance.

 

 41 


   

Income tax expense

Our income tax provision was $2.0 million expense and $1.6 million benefit for the three months ended September 30, 2013 and 2012, respectively. Our effective tax rate was 52.8% expense and 9.6% benefit for the three months ended September 30, 2013 and 2012, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and the change in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of September 30, 2013, a valuation allowance of $98.3 million has been provided for net operating loss carryforwards and other deferred tax assets. We increased our valuation allowance by $3.6 million for the three months ended September 30, 2013, of which $3.5 million represents current period net operating losses and $0.1 million represents changes in other comprehensive income (loss).  We increased our valuation allowance by $9.8 million for the three months ended September 30, 2012, due to net operating losses. Excluding the change in our valuation allowance, our effective tax rate would have been 38.3% and 66.4% benefit for the three months ended September 30, 2013 and 2012, respectively, primarily due to the mix of pre-tax income or loss earned in certain tax jurisdictions.

Our pre-tax income is generated in a number of jurisdictions and is subject to a number of different effective tax rates that are significantly lower than the U.S. corporate statutory tax rate of 35.0%. For the three months ended September 30, 2013, we earned $1.1 million of pre-tax income in jurisdictions with an expected full year effective tax rate of 9.6%. For the three months ended September 30, 2012, we earned $13.2 million of pre-tax income in jurisdictions with an expected full year effective tax rate of 10.2%.

Net loss attributable to Kraton

Net loss attributable to Kraton was $(5.6) million or $(0.17) per diluted share for the three months ended September 30, 2013, an improvement of $9.9 million compared to net loss of $(15.5) million or $(0.48) per diluted share for the three months ended September 30, 2012.

Net loss for the three months ended September 30, 2013 included the following:

 

·

Restructuring and other charges of $1.0 million or $0.03 per diluted share

 

·

Production downtime related to MACT legislation of $3.5 million or $0.11 per diluted share

 

·

Negative spread between FIFO and ECRC of $20.7 million or $0.63 per diluted share

Net loss for the three months ended September 30, 2012 included the following:

 

·

Storm related benefit of $0.2 million or $0.01 benefit per diluted share

 

·

Impairment of long-lived assets of $3.5 million or $0.11 per diluted share

 

·

Negative spread between FIFO and ECRC of $36.7 million or $1.13 per diluted share

In addition, the impact of the change in our deferred tax asset valuation allowance decreased our diluted earnings per share by $0.11 during the three months ended September 30, 2013 and $0.30 per diluted share during the three months ended September 30, 2012.

Nine Months Ended September 30, 2013 Compared to Nine Months Ended September 30, 2012

Sales Revenue

Sales revenue amounted to $1,001.8 million for the nine months ended September 30, 2013 compared to $1,126.7 million for the nine months ended September 30, 2012. The $124.9 million or 11.1% revenue decline (a decline of $117.2 million or 10.4% excluding a $7.7 million effect of currency fluctuations) was largely due to a reduction in global product sales prices associated with lower average raw material costs of $78.8 million and $37.3 million related to lower sales volumes. Sales volumes were 239.2 kilotons for the nine months ended September 30, 2013 compared to 246.1 kilotons for the nine months ended September 30, 2012, a decrease of 6.9 kilotons or 2.8%, significantly all of which was driven by lower paving demand in North America and Europe.

 

 42 


   

With respect to sales revenue in each of our end use markets:

 

·

Advanced Materials. Sales revenue amounted to $268.9 million for the nine months ended September 30, 2013 compared to $301.4 million for the nine months ended September 30, 2012. The $32.5 million or 10.8% revenue decline (a decline of $30.6 million or 10.2% excluding a $1.9 million effect of currency fluctuations) was primarily due to lower average selling prices, reflective of lower average raw materials costs, primarily butadiene and to a lesser extent a 1.4% decline in sales volumes. With respect to innovation sales volumes, we experienced growth in personal care applications, partially offset by lower sales volumes in wire and cable applications.   

 

·

Adhesives, Sealants and Coatings. Sales revenue amounted to $375.1 million for the nine months ended September 30, 2013 compared to $401.3 million for the nine months ended September 30, 2012. The $26.3 million or 6.5% revenue decline (a decline of $22.0 million or 5.5% excluding a $4.2 million effect of currency fluctuations) was primarily due to lower average selling prices indicative of lower raw material costs, primarily butadiene and isoprene, as sales volumes were essentially flat.

 

·

Paving and Roofing. Sales revenue amounted to $272.3 million for the nine months ended September 30, 2013 compared to $345.2 million for the nine months ended September 30, 2012. The $72.9 million or 21.1% revenue decline (a decline of $74.7 million or 21.6% excluding a $1.8 million effect of currency fluctuations) was primarily due to lower average selling prices indicative of lower raw material costs, primarily butadiene and a 6.7% decline in sales volumes driven by lower paving demand principally in North America and Europe.  Innovation sales volumes grew on strong performance for roofing applications.

 

·

CariflexTM. Sales revenue amounted to $84.5 million for the nine months ended September 30, 2013 compared to $76.6 million for the nine months ended September 30, 2012. The $7.9 million or 10.3% revenue increase (an increase of $11.2 million or 14.7% excluding a $3.4 million effect of currency fluctuations) reflects higher sales volumes, mainly for the surgical glove market and other medical and innovation applications, as well as increased average selling prices across the majority of the Cariflex portfolio.

Cost of Goods Sold

Cost of goods sold amounted to $834.5 million for the nine months ended September 30, 2013 compared to $935.0 million for the nine months ended September 30, 2012. The $100.4 million or 10.7% decrease was driven largely by an $88.7 million reduction in raw material costs, which included a $3.2 million increase associated with the change in the spread from FIFO to ECRC, a $25.3 million reduction due to lower sales volumes, a $2.5 million reduction due to changes in foreign currency exchange rates, and the absence of net charges amounting to $2.3 million recorded in 2012, which related to the property tax dispute in France, storm-related charges, restructuring and other charges and the LBI settlement. Partially offsetting these decreases in cost of goods sold were increases from the production downtime related to the MACT legislation of $3.5 million, increased turnaround costs of $2.7 million, and other increases in cost of goods sold, including production inefficiencies in the first quarter of 2013.

Gross Profit

Gross profit amounted to $167.2 million for the nine months ended September 30, 2013 compared to $191.8 million for the nine months ended September 30, 2012. The $24.5 million or 12.8% decrease includes a $3.2 million negative impact associated with the spread between FIFO and ECRC.  Gross profit at ECRC was $190.7 million for the nine months ended September 30, 2013 compared to $212.0 million for the nine months ended September 30, 2012, a decrease of $21.4 million or 10.1%, largely due to the factors discussed in “Cost of Goods Sold.”  Gross profit as a percentage of sales revenue was 16.7% and 17.0% for the nine months ended September 30, 2013 and 2012, respectively.

Operating Expenses

 

·

Research and Development. Research and development expenses increased $0.8 million or 3.6% primarily due to an increase in employee related and operational costs, partially offset by decreased lease expense for our research and development facilities. Research and development expenses were 2.4% and 2.0% of sales revenue for the nine months ended September 30, 2013 and 2012, respectively.

 

 43 


   

   

 

·

Selling, General and Administrative. Selling, general and administrative expenses decreased $2.7 million or 3.5%. The decrease was primarily due to a $4.1 million decrease in employee related costs, lower legal expenses of $0.9 million, a $0.6 million charge associated with the resolution of a property tax dispute in France during 2012, and a $0.2 million decrease in lease expense, partially offset by a $2.2 million increase in restructuring and other costs, a $1.0 million increase in other professional fees and a $0.8 million increase in costs associated with the joint venture with FPCC. Selling, general and administrative expenses were 7.3% and 6.8% of sales revenue for the nine months ended September 30, 2013 and 2012, respectively.

 

·

Depreciation and Amortization. Depreciation and amortization decreased $1.2 million or 2.5%, primarily due to the extended compliance deadline for our coal-burning boilers at our Belpre, Ohio, facility, pursuant to the revised MACT rule.

 

·

Impairment of long-lived assets. During the nine months ended September 30, 2012, we recorded a pre-tax charge of $5.4 million in the aggregate for the impairment of long-lived assets, of which $3.4 million was related to the HSBC facility in Mailiao, Taiwan and $2.0 million related to other long-lived assets.

Interest expense, net

Interest expense, net increased $2.8 million or 12.9% to $24.9 million for the nine months ended September 30, 2013 from $22.1 million for the nine months ended September 30, 2012. The increase was primarily due to a $5.0 million write off of debt issuance costs and a $0.7 million payment to exit a 2011 interest rate swap agreement associated with replacing and refinancing our previous credit facilities, partially offset by a lower average debt balance.

Income tax expense

Our income tax expense was $4.4 million for both the nine months ended September 30, 2013 and 2012. Our effective tax rate was 329.5% and 24.7% for the nine months ended September 30, 2013 and 2012, respectively. Our effective tax rates differed from the U.S. corporate statutory tax rate of 35.0%, primarily due to the mix of pre-tax income or loss earned in certain jurisdictions and the change in our valuation allowance.

We record a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of September 30, 2013 and December 31, 2012, a valuation allowance of $98.3 million and $90.4 million, respectively, has been provided for net operating loss carryforwards and other deferred tax assets. We increased our valuation allowance by $7.9 million for the nine months ended September 30, 2013, of which $8.0 million represents current period net operating losses, partially offset by $0.1 million, which represents changes in other comprehensive income (loss). We increased our valuation allowance by $9.6 million for the nine months ended September 30, 2012, due to net operating losses. Excluding the change in our valuation allowance, our effective tax rate would have been a 276.9% and a 29.1% benefit for the nine months ended September 30, 2013 and 2012, respectively, primarily due to the mix of pre-tax income or loss earned in certain tax jurisdictions.

Our pre-tax income is generated in a number of jurisdictions and is subject to a number of different effective tax rates that are significantly lower than the U.S. corporate statutory tax rate of 35.0%. For the nine months ended September 30, 2013, we earned $17.1 million of pre-tax income in jurisdictions with an expected full year effective tax rate of 9.6%. For the nine months ended September 30, 2012, we earned $55.8 million of pre-tax income in jurisdictions with an expected full year effective tax rate of 10.2%.

Net income (loss) attributable to Kraton

Net loss attributable to Kraton was $(5.5) million or $(0.17) per diluted share for the nine months ended September 30, 2013, a decrease of $18.8 million compared to net income of $13.3 million or $0.41 per diluted share for the nine months ended September 30, 2012.

Net loss for the nine months ended September 30, 2013 included the following:

 

·

Restructuring and other charges of $2.3 million or $0.07 per diluted share

 

·

Charges associated with the credit facility refinancing of $5.8 million or $0.18 per diluted share

 

 44 


   

   

 

·

Production downtime related to MACT legislation of $3.5 million or $0.11 per diluted share

 

·

Negative spread between FIFO and ECRC of $23.5 million or $0.72 per diluted share

Net income for the nine months ended September 30, 2012 included the following:

 

·

Benefit of the LBI settlement of $6.9 million or $0.21 benefit per diluted share

 

·

Settlement of property tax dispute in France of $6.2 million or $0.19 per diluted share

 

·

Restructuring and other charges of $0.8 million or $0.02 per diluted share

 

·

Storm related charges of $1.6 million or $0.05 per diluted share

 

·

Impairment of long-lived assets of $3.5 million or $0.11 per diluted share

 

·

Negative spread between FIFO and ECRC of $19.3 million or $0.60 per diluted share

In addition, the impact of the change in our deferred tax asset valuation allowance decreased our diluted earnings per share by $0.25 during the nine months ended September 30, 2013 and decreased our diluted earnings per share by $0.29 during the nine months ended September 30, 2012.

Critical Accounting Policies

For a discussion of our critical accounting policies and estimates that require the use of significant estimates and judgments, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2012.

 

 45 


   

EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC

We consider EBITDA, Adjusted EBITDA, Adjusted EBITDA at estimated current replacement cost (ECRC) and Gross Profit at ECRC to be important supplemental measures of our performance and believe they are frequently used by investors, securities analysts and other interested parties in the evaluation of our performance including period-to-period comparisons. In addition, management uses these measures to evaluate operating performance, and our executive compensation plan bases incentive compensation payments on our Adjusted EBITDA and Adjusted EBITDA at ECRC performance, along with other factors. EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC have limitations as analytical tools and in some cases can vary substantially from other measures of our performance. You should not consider any of them in isolation, or as substitutes for analysis of our results under U.S. generally accepted accounting principles (“GAAP”).

   

 

   

Three months ended
September 30,

   

      

Nine months ended
September 30,

   

   

2013

   

      

2012

   

      

2013

   

      

2012

   

   

(in thousands)

   

      

(in thousands)

   

EBITDA (1)

$

17,724

      

      

$

6,604

      

      

$

70,274

      

      

$

87,571

      

Adjusted EBITDA (2)

$

24,104

      

      

$

13,210

      

      

$

82,444

      

      

$

101,185

      

Adjusted EBITDA at ECRC (3)

$

44,754

      

      

$

50,846

      

      

$

105,905

      

      

$

121,482

      

Gross Profit at ECRC (3)

$

68,100

      

      

$

80,389

      

      

$

190,683

      

      

$

212,049

      

   

 

   

(1)

EBITDA represents net income before interest, taxes, depreciation and amortization.

 

      

Limitations for EBITDA as an analytical tool include the following:

 

·

EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;

 

·

EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

·

EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest payments, on our debt;

 

·

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and EBITDA does not reflect any cash requirements for such replacements;

 

·

EBITDA calculation under the terms of our debt agreements may vary from EBITDA presented herein, and our presentation of EBITDA herein is not for purposes of assessing compliance or non-compliance with financial covenants under our debt agreements;

 

·

other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure; and

 

·

EBITDA is not a measure of discretionary cash available to us to invest in the growth of our business.

 

(2)

We prepare Adjusted EBITDA by adjusting EBITDA to eliminate the impact of a number of items we do not consider indicative of our ongoing operating performance. We explain how each adjustment is derived and why we believe it is helpful and appropriate in the reconciliation below. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. As an analytical tool, Adjusted EBITDA is subject to the limitations applicable to EBITDA described above. In addition, in evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

 

 46 


   

 

(3)

Adjusted EBITDA at ECRC is Adjusted EBITDA net of the impact of the spread between the FIFO basis of accounting and ECRC and Gross Profit at ECRC is gross profit net of the impact of the spread between the FIFO basis of accounting and ECRC. Although we report our financial results using the FIFO basis of accounting, as part of our pricing strategy, we measure our business performance using the estimated current replacement cost of our inventory and cost of goods sold. We maintain our perpetual inventory in our global enterprise resource planning system. The carrying value of our inventory is determined using FIFO. At the beginning of each month, we determine the estimated current cost of our raw materials for that particular month, and using the same perpetual inventory system that we use to manage inventory and therefore costs of goods sold under FIFO, we revalue our ending inventory to reflect the total cost of such inventory as if it was valued using the estimated current replacement cost. The result of this revaluation from FIFO creates the spread between FIFO and ECRC. With inventory valued under FIFO and ECRC, we then have the ability to report cost of goods sold and therefore EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC, Gross Profit, and Gross Profit at ECRC under both our FIFO convention and under estimated current replacement cost. As an analytical tool, Adjusted EBITDA at ECRC is subject to the limitations applicable to EBITDA described above, as well as the following limitations:

 

·

due to volatility in raw material prices, Adjusted EBITDA at ECRC may, and often does, vary substantially from EBITDA, net income and other performance measures, including net income calculated in accordance with US GAAP; and

 

·

Adjusted EBITDA at ECRC may, and often will, vary significantly from EBITDA calculations under the terms of our debt agreements and should not be used for assessing compliance or non-compliance with financial covenants under our debt agreements.

Our presentation of Adjusted EBITDA at ECRC should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

As a measure of our performance, Gross Profit at ECRC is limited because it often varies substantially from gross profit calculated in accordance with US GAAP due to volatility in raw material prices.

 

      

We compensate for these limitations by relying primarily on our GAAP results and using EBITDA, Adjusted EBITDA, Adjusted EBITDA at ECRC and Gross Profit at ECRC only as supplemental measures.

We reconcile Gross Profit to Gross Profit at ECRC as follows:

   

 

   

Three months ended
September 30,

   

      

Nine months ended
September 30,

   

   

2013

   

      

2012

   

      

2013

   

      

2012

   

   

(in thousands)

   

      

(in thousands)

   

Gross profit

$

47,450

      

      

$

42,753

      

      

$

167,222

      

      

$

191,752

      

Add:

   

   

   

      

   

   

   

      

   

   

   

      

   

   

   

Spread between FIFO and ECRC

   

20,650

      

      

   

37,636

      

      

   

23,461

      

      

   

20,297

      

Gross profit at ECRC

$

68,100

      

      

$

80,389

      

      

$

190,683

      

      

$

212,049

      

   

   

 

 47 


   

   

 

      

We reconcile consolidated net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA at ECRC as follows:

   

 

   

Three months ended
September 30,

   

   

Nine months ended
September 30,

   

   

2013

   

      

2012

   

   

2013

   

      

2012

   

   

(in thousands)

   

   

(in thousands)

   

Net income (loss) attributable to Kraton

$

(5,598

      

$

(15,499

   

$

(5,517

      

$

13,261

      

Net loss attributable to noncontrolling interest

   

(254

      

   

0

      

   

   

(182

      

   

0

      

Consolidated net income (loss)

   

(5,852

      

   

(15,499

   

   

(5,699

      

   

13,261

      

Add:

   

   

   

      

   

   

   

   

   

   

   

      

   

   

   

Interest expense, net

   

5,741

      

      

   

7,634

      

   

   

24,948

      

      

   

22,106

      

Income tax expense (benefit)

   

2,021

      

      

   

(1,640

   

   

4,372

      

      

   

4,361

      

Depreciation and amortization expenses

   

15,814

      

      

   

16,109

      

   

   

46,653

      

      

   

47,843

      

EBITDA

   

17,724

      

      

   

6,604

      

   

   

70,274

      

      

   

87,571

      

Add (deduct):

   

   

   

      

   

   

   

   

   

   

   

      

   

   

   

Settlement gain (a)

   

0

      

      

   

0

      

   

   

0

      

      

   

(6,819

Property tax dispute (b)

   

0

      

      

   

0

      

   

   

0

      

      

   

6,211

      

Storm related charges (c)

   

0

      

      

   

(336

   

   

0

      

      

   

2,481

      

Restructuring and other charges (d)

   

1,041

      

      

   

0

      

   

   

2,302

      

      

   

1,062

      

Impairment of long-lived assets (e)

   

0

      

      

   

5,434

      

   

   

0

      

      

   

5,434

      

Production downtime related to MACT legislation (f)

   

3,506

      

      

   

0

      

   

   

3,506

      

      

   

0

   

Non-cash compensation expense (g)

   

1,833

      

      

   

1,508

      

   

   

6,362

      

      

   

5,245

      

Adjusted EBITDA

   

24,104

      

      

   

13,210

      

   

   

82,444

      

      

   

101,185

      

Add:

   

   

   

      

   

   

   

   

   

   

   

      

   

   

   

Spread between FIFO and ECRC

   

20,650

      

      

   

37,636

      

   

   

23,461

      

      

   

20,297

      

Adjusted EBITDA at ECRC

$

44,754

      

      

$

50,846

      

   

$

105,905

      

      

$

121,482

      

   

 

   

(a)

Reflects the benefit of the LBI settlement, which is recorded in cost of goods sold.

(b)

Reflects the charge associated with the resolution of the property tax dispute in France, of which $5,646 is recorded in cost of goods sold and $565 is recorded in selling, general and administrative expenses.

(c)

Reflects the storm related charge at our Belpre, Ohio facility, which is recorded in cost of goods sold.

(d)

Includes other professional fees, severance expenses and fees associated with the public offering of our senior notes, which are primarily recorded in selling, general and administrative expenses in 2013 and primarily in cost of goods sold in 2012.

(e)

Reflects the impairment of long-lived assets, of which $3.4 million and $2.0 million were associated with the HSBC facility and other long-term assets, respectively.

(f)

Reflects the non-recurring portion of the $6.1 million of aggregate turnaround costs in 2013. The adjustment relates to the production downtime at our Belpre, Ohio facility, in preparation for the installation of natural gas boilers to replace the coal-burning boilers required by the MACT legislation, which is recorded in cost of goods sold.

(g)

We have historically recorded these costs in selling, general and administrative expenses; however, beginning in the second quarter of 2013, a portion of these costs were recorded in cost of goods sold and research and development expenses.   

   

 

 48 


   

LIQUIDITY AND CAPITAL RESOURCES

Known Trends and Uncertainties

Kraton Performance Polymers, Inc. is a holding company without any operations or assets other than the operations of its subsidiaries.

In March 2013, we entered into an asset-based revolving credit facility consisting of a U.S. senior secured revolving credit facility of $150.0 million and a Dutch senior secured revolving credit facility of $100.0 million (the “Senior Secured Credit Facilities”), to replace our then existing senior secured credit facility, and repaid in full all outstanding amounts payable under the previously existing indebtedness. The facilities are secured by receivables and inventory, and borrowing availability under the Senior Secured Credit Facilities is subject to borrowing base limitations based on the level of receivables and inventory available for security. The Senior Secured Credit Facilities include a $100.0 million uncommitted accordion feature that, subject to borrowing base availability and approval of the bank syndicate, could increase aggregate availability to $350.0 million. We cannot guarantee that all of the counterparties contractually committed to fund a revolving credit draw request will actually fund future requests, although we currently believe that each of the counterparties would meet their funding requirements.

The Senior Secured Credit Facilities contain a financial covenant and certain customary events of default, including, without limitation, a failure to make payments under the facility, cross-default and cross-judgment default, certain bankruptcy events and certain change of control events. Our failure to comply with the covenants would give rise to a default under the Senior Secured Credit Facilities. If factors arise that negatively impact our profitability, we may not be able to satisfy the covenants. If we are unable to satisfy such covenants or other provisions at any future time we would need to seek an amendment or waiver of such covenants or other provisions. The respective lenders under the Senior Secured Credit Facilities may elect not to consent to any amendment or waiver requests that we may make in the future, and, if they do consent, they may do so on terms that are not favorable to us. In the event that we were unable to obtain any such waiver or amendment and we were not able to refinance or repay our Senior Secured Credit Facilities, our inability to meet the covenants or other provisions of the Senior Secured Credit Facilities would constitute an event of default, which would permit the bank lenders to accelerate the Senior Secured Credit Facilities. Such acceleration may in turn constitute an event of default under our senior notes. At September 30, 2013, we were in compliance with the covenants under the Senior Secured Credit Facilities and the indenture governing our 6.75% senior notes.

The Senior Secured Credit Facilities terminate on March 27, 2018, however we may, from time to time, request that the lenders extend the maturity of their commitments; provided that at no time shall there be more than four maturity dates under the Senior Secured Credit Facilities.

Based upon current and anticipated levels of operations, we believe that cash flows from operations of our subsidiaries, cash on hand, and borrowings available to us will be sufficient to fund our working capital requirements, our investment in the joint venture with FPCC, debt payments, interest payments, capital expenditures, benefit plan contributions and income tax obligations. However, these cash flows are subject to a number of factors, including, but not limited to, earnings, sensitivities to the cost of raw materials, seasonality and fluctuations in foreign currency exchange rates. Because feedstock costs generally represent a substantial portion of our cost of goods sold, in periods of rising feedstock costs, we generally consume cash in operating activities due to increases in accounts receivable and inventory costs, partially offset by increased value of accounts payable. Conversely, during periods in which feedstock costs are declining, we generate cash flow from decreases in working capital.

Going forward there can be no assurance that our business will generate sufficient cash flow from operations or that future borrowings will be available under our senior secured credit facilities to fund liquidity needs and enable us to service our indebtedness. At September 30, 2013, we had $144.6 million of cash and cash equivalents, which includes $48.9 million of cash-on-hand at KFPC, the consolidated joint venture in Asia. As of September 30, 2013, our available borrowing capacity was $187.3 million of which $0 million was drawn and as of the date of this filing, our available borrowing capacity was $196.4 million, of which $0 million was drawn. Excluding the $48.9 million of KFPC cash, our liquidity at September 30, 2013 amounted to $283.0 million. Our available cash and cash equivalents are held in accounts managed by third-party financial institutions and consist of cash invested in interest bearing funds and operating accounts. To date, we have not experienced any losses or lack of access to our invested cash or cash equivalents; however, we cannot provide any assurance that adverse conditions in the financial markets will not impact access to our invested cash and cash equivalents.

 

 49 


   

For additional information regarding our Senior Secured Credit Facilities, see “—Senior Secured Credit Facilities” in Note 6 Long-Term Debt to the condensed consolidated financial statements, which is incorporated herein by reference.

We made contributions of $4.8 million to our pension plan in the nine months ended September 30, 2013 and $6.8 million for the nine months ended September 30, 2012. We expect our total pension plan contributions for the year ended December 31, 2013 to be $6.2 million. Our pension plan obligations are predicated on a number of factors, the primary ones being the return on our pension plan assets and the discount rate used in deriving our pension obligations. If the investment return on our pension plan assets does not meet or exceed expectations during 2013, and the discount rate decreases from the prior year, higher levels of contributions could be required in 2014 and beyond.

As of September 30, 2013, we had $134.2 million of cash and short-term investments related to foreign operations that management asserts are permanently reinvested. As a result of net operating loss carryforwards, management estimates that no additional cash tax expense would be incurred if this cash were repatriated.

Turbulence in U.S. and international markets and economies may adversely affect our liquidity and financial condition, the liquidity and financial condition of our customers, and our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations. However, to date we have been able to access borrowings available to us in amounts sufficient to fund liquidity needs. Total receivables, net of allowances, for customers located in Italy, Spain, Portugal, Greece and Ireland aggregated approximately $7.1 million at September 30, 2013. We have not incurred to date, nor do we currently expect to incur any material losses associated with these trade receivables.

Our ability to pay principal and interest on our indebtedness, fund working capital, make anticipated capital expenditures and fund our investment in the joint venture with FPCC depends on our future performance, which is subject to general economic conditions and other factors, some of which are beyond our control. “See Part I, Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2012 for further discussion.

Operating Cash Flows and Liquidity

Net cash provided by operating activities totaled $58.1 million for the nine months ended September 30, 2013 and $102.2 million for the nine months ended September 30, 2012. This represents a net decrease of $44.1 million, which was driven by a decrease in net income and changes in working capital. The net change in working capital was a source of cash of $6.8 million in 2013 compared to a source of cash of $34.0 million in 2012; a period-over-period decline in cash flows of $27.2 million. The period-over-period changes are as follows:

 

·

$27.5 million less cash flows associated with inventories of products, materials and supplies, largely due to changes in the quantity of raw material inventories and the costs of raw materials on total inventories;

 

·

$16.0 million less cash flows associated with trade accounts payable primarily due to the cost of raw materials and the timing of payments; partially offset by

 

·

$11.9 million net increase in cash flows due to the timing of payments of other items, including taxes, payments to a related party and pension costs; and

 

·

$4.3 million increase in cash flows associated with accounts receivable reflecting changes in sales volume and revenue per ton, as well as the timing of cash receipts.

Investing Cash Flows

Net cash used in investing activities totaled $63.5 million for the nine months ended September 30, 2013 and $42.6 million for the nine months ended September 30, 2012.

Expected Capital Expenditures. We currently expect 2013 capital expenditures, excluding funding for the joint venture with FPCC, will be approximately $80.0 million to $85.0 million. Included in this estimate is approximately $17.6 million related to the semi-works facility, approximately $15.9 million to comply with the MACT rule, of which $1.4 million will be financed with a capital lease, and approximately $19.0 million to $22.0 million for health, safety and environmental and infrastructure and maintenance

 

 50 


   

projects. The remaining anticipated 2013 capital expenditures are primarily associated with projects to optimize the production capabilities of our manufacturing assets and to support our innovation platform. In addition, at this time, after completing our initial engineering estimate, we anticipate the total FPCC joint venture project construction cost will be at least $200.0 million. We and FPCC intend to pursue opportunities to obtain debt financing for project costs at the joint venture level. Based on our current assumptions with respect to final project cost, timing and the extent to which the project can be funded through third-party debt financing, we estimate our share of the funding for the joint venture will be approximately $50.0 million of which $30.2 million has been funded during the nine months ended September 30, 2013, and approximately $11.4 million is estimated to be funded in the remainder of 2013. We currently anticipate funding our remaining 2013 contributions with available liquidity.

Financing Cash Flows

Our consolidated capital structure as of September 30, 2013 was approximately 56% equity, 40% debt and 4% noncontrolling interest compared to approximately 54% equity and 46% debt as of September 30, 2012.

Net cash used in financing activities totaled $72.1 million for the nine months ended September 30, 2013 compared to net cash provided by financing activities of $53.3 million for the nine months ended September 30, 2012, representing a period-over-period decline in cash from financing activities of $125.4 million. In 2013, we repaid the remaining $96.9 million of term loans and received $30.2 million from FPCC, which represents their portion of the equity investment in the joint venture, resulting in net cash used by financing activities of $66.7 million. In 2012, we increased the amount outstanding under the 6.75% Senior Notes by $100.0 million and made a $40.0 million voluntary prepayment on the term loan portion of the senior secured credit facility, resulting in net cash provided by financing activities of $60.0 million.  

Description of 6.75% Senior Notes due 2019

Kraton Polymers LLC and its wholly-owned financing subsidiary Kraton Polymers Capital Corporation issued $350.0 million aggregate principal amount of 6.75% senior notes that mature on March 1, 2019. The notes are general unsecured, senior obligations and are unconditionally guaranteed on a senior unsecured basis. We pay interest on the notes at 6.75% per annum, semi-annually in arrears on March 1 and September 1 of each year. Prior to March 1, 2015, we may redeem all or a part of the senior notes, at a redemption price equal to 100.00% of the principal amount of the senior notes redeemed plus the applicable premium as of, plus accrued and unpaid interest, if any, to the applicable redemption date. After March 1, 2015, we may redeem all or a part of the senior notes for 103.375%, 101.688%, and 100.000% of the principal amount in 2015, 2016 and 2017 and thereafter, respectively. See Note 6 Long-Term Debt, for further discussion.

Contractual Commitments

Our contractual obligations are summarized in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our annual report on Form 10-K for the period ended December 31, 2012. Other than the refinancing of our indebtedness in March 2013 and our minimum purchase obligations required under our KFPC joint venture agreements, there have been no other material changes to the contractual obligation amounts disclosed in our quarterly report on Form 10-Q for the period ended March 31, 2013 and our annual report on Form 10-K for the year ended December 31, 2012.

Off-Balance Sheet Arrangements

We are not involved in any material off-balance sheet arrangements as of September 30, 2013, other than operating leases.

   

 

 51 


   

Item 3.

Quantitative and Qualitative Disclosures about Market Risk.

For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our annual report on Form 10-K for the year ended December 31, 2012. There have been no material changes to the quantitative and qualitative disclosures about market risk disclosed in our annual report on Form 10-K for the year ended December 31, 2012. See Note 8 Fair Value Measurements, Financial Instruments and Credit Risk for further discussion.

   

Item 4.

Controls and Procedures.

An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934) was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. As of September 30, 2013, based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective.

There has been no change in our internal control over financial reporting that occurred during the three months ended September 30, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

   

   

 

 52 


   

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings.

For information regarding legal proceedings, see Note 10 Commitments and Contingencies, to our condensed consolidated financial statements.

   

Item 1A.

Risk Factors.

Readers of this Quarterly Report on Form 10-Q should carefully consider the risks described in our other reports filed with or furnished to the SEC, including our prior and subsequent reports on Forms 10-K, 10-Q and 8-K, in connection with any evaluation of our financial position, results of operations and cash flows.

The risks and uncertainties in our most recent Annual Report on Form 10-K, are not the only ones facing us. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect our operations. Any of the risks, uncertainties, events or circumstances described therein could cause our future financial condition, results of operations or cash flows to be adversely affected.

   

   

 

 53 


   

Item 6.

Exhibits.

   

 

Exhibit Number

   

   

   

10.1

   

Executive Compensation Recoupment Policy (adopted September 11, 2013) (incorporated by reference to Exhibit 10.1 to Kraton Performance Polymers, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2013)

   

   

   

10.2

   

First Amendment to Kraton Performance Polymers, Inc. 2013 Cash Incentive Plan (incorporated by reference to Exhibit 10.2 to Kraton Performance Polymers, Inc.’s Current Report on Form 8-K filed with the SEC on September 16, 2013)

   

   

   

10.3+*

   

Form of Kraton Performance Polymers, Inc. Stock Option Award Agreement under the 2009 Equity Incentive Plan

   

   

   

10.4+*

   

Form of Kraton Performance Polymers, Inc. Restricted Stock Award Agreement under the 2009 Equity Incentive Plan

   

   

   

10.5+*

   

Form of Kraton Performance Polymers, Inc. Restricted Stock Unit Award Agreement under the 2009 Equity Incentive Plan

   

   

   

10.6+*

   

Form of Kraton Performance Polymers, Inc. Restricted Stock Performance Unit Award Agreement under the 2009 Equity Incentive Plan

   

   

   

31.1*

   

Certification of Chief Executive Officer under Section 302 of Sarbanes—Oxley Act of 2002

   

   

   

31.2*

   

Certification of Chief Financial Officer under Section 302 of Sarbanes—Oxley Act of 2002

   

   

   

32.1*

   

Certification Pursuant to Section 906 of Sarbanes—Oxley Act of 2002

   

   

   

101

   

The following materials from Kraton Performance Polymers, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2013 and December 31, 2012 (Unaudited), (ii) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012 (Unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2013 and 2012 (Unaudited), (iv) Condensed Consolidated Statements of Changes in Equity for the nine months ended September 30, 2013 and 2012 (Unaudited), (v) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2013 and 2012 (Unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (Unaudited).

   

 

   

+

Denotes management contract or compensatory plan or arrangement.

*

Filed herewith.

   

   

 

 54 


   

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   

 

   

   

KRATON PERFORMANCE POLYMERS, INC.

Date:

October 31, 2013

/s/    Kevin M. Fogarty

   

   

Kevin M. Fogarty

   

   

President and Chief Executive Officer

   

   

   

Date:

October 31, 2013

/s/    Stephen E. Tremblay

   

   

Stephen E. Tremblay

   

   

Vice President and Chief Financial Officer

   

 

 55